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ABSTRACT 
 
Background and Rationale: Reproductive dysfunction affects more than 15% of Canadian 
women; however, the underlying causes remain largely unknown. Ultrasonography is the most 
commonly used research and diagnostic tool for imaging the ovaries and uterus.  However, 
current ultrasonographic techniques allow the detection of ovarian structures (eg. follicles, 
corpora lutea) at diameters of only ≥2 mm. The increased effectiveness of synchrotron 
technology for imaging ovaries in comparison to conventional imaging methods is currently 
unknown. 
 
Overall Objective: The overall objective of this research was to determine the effectiveness of 
synchrotron techniques for imaging ovaries. We hypothesized that synchrotron techniques 
would provide greater contrast for visualizing structural details of follicles, corpora lutea (CL), 
and cumulus oocyte complexes (COC), compared to conventional ultrasonography.  
 
Materials and Methods: Three studies were conducted to evaluate phase-contrast based 
synchrotron imaging methods. The first study involved Diffraction Enhanced Imaging (DEI) of 
bovine ovaries (n=6). The second study involved Propagation-Based Computed Tomography 
(PB-CT) imaging of bovine (n=4) and human ovaries (n=4). A third, preliminary study was 
conducted to explore the use of Talbot Grating Interferometry (TGI-CT) imaging of bovine 
(n=1) and human ovaries (n=1). Fresh and formalin-fixed bovine and human ovaries were 
imaged without or with contrast injection into the ovarian artery. Following synchrotron 
imaging, all ovarian samples were evaluated using diagnostic ultrasonography and histology. 
Images obtained using synchrotron techniques, ultrasonography and histology were qualitative 
and quantitatively compared. 
 
Results: DEI allowed the identification of 71% of follicles ≥2 mm and 67% of CL detected 
using ultrasonography. Mean follicle diameter was similar between DEI (9.6 ± 2.4 mm), 
ultrasonography (9.0 ± 2.6 mm), and histology (6.9 ± 1.9 mm) for fresh ovaries without contrast 
(P = 0.70). Likewise, no difference in CL diameter was detected between DEI (11.64 ± 1.67 
mm), ultrasonography (9.34 ± 0.35 mm), and histology (9.6 ± 0.4 mm), (P = 0.34). Antral 
iii 
Follicle Count (AFC;  ≥2 mm) was similar between ultrasonography (6.5 ± 0.7 mm, fresh with 
no contrast; 6.5 ± 2.5 mm, preserved with no contrast) and DEI ( 4.5 ± 0.5 mm, fresh with no 
contrast; 6.5 ± 0.50 mm, preserved with no contrast) (P > 0.05). However, the contrast 
resolution for differentiating follicles and CL was inferior with DEI compared to 
ultrasonography. Small antral follicles <2 mm, cell layers comprising the follicle wall and COC 
were not detected using either DEI or ultrasonography.  
PB-CT imaging enabled the visualization of 100% of follicles ≥2 mm and 100% of CL 
that were detected with ultrasonography. CL containing a central cystic cavity were identified 
using PB-CT; however, CL without a central cystic cavity were not well-visualized. Mean 
follicle and luteal diameters did not differ among PB-CT, ultrasonography and histology 
(P>0.05). PB-CT was superior to ultrasonography for detecting small antral follicles <2 mm in 
bovine ovaries (P = 0.04), and the granulosa and theca cell layers of the follicle wall in bovine 
and human ovaries (P < 0.0001). However, TGI-CT images exhibited greater contrast resolution 
for visualizing small and large antral follicles, CL, and the cell layers of the follicle wall 
compared to both PB-CT and ultrasonography. High contrast structures resembling COC were 
detected with both PB-CT and TGI-CT, but not with ultrasonography. Only TGI-CT permitted 
the visualization of the oocyte within the COC in fresh and preserved ovaries.  
 
Conclusions:  DEI was inferior to ultrasonography for detecting ovarian follicles and CL. PB-
CT was superior to ultrasonography for visualizing follicles <2mm, COC, and the cell layers of 
the follicle wall. However, PB-CT was as effective as ultrasonography for detecting and 
measuring follicles ≥2 mm and cystic CL. Preliminary findings suggest that TGI-CT provides 
the greatest contrast for imaging both ovarian macro- and microanatomy compared to PB-CT, 
DEI, and ultrasonography. 
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Chapter 1 
GENERAL INTRODUCTION 
 
1.1 The Human Ovary 
1.1.1 Historical Perspective on Human Ovarian Research 
The study of the structure and function of the human ovary has been of interest to 
scientists and clinicians for several decades. The ovaries house the female germ cells, oocytes, 
which are essential for procreation. Soranus of Ephesus (Greece, 100 CE) described the ovaries 
as a didymi (“paired organs”) with a loose texture, but concluded that the female seed (egg) had 
no role in reproduction since it was excreted with urine [1, 2]. The term “ovary” was later 
created by Girolamo Fabrici d’Aquapendente (Italy, 1600) [3]. The follicles (i.e., the fluid-filled 
sacs containing the oocytes within the ovary) were first described by Andreas Vesalius 
(Belgium) in the 1540s [3]. Mature ovarian follicles were characterized by Regnier de Graaf 
(Netherlands, 1672); however, de Graaf  had assumed that the follicle itself was the egg [2, 3]. 
The distinction between the egg and the follicle was made in 1827 by Karl Ernst von Baer 
(Russia)[2, 3]. During the nineteenth century, surgical examination of the reproductive organs 
allowed a better understanding of the structures within the ovaries, including antral follicles, 
corpora lutea (CL), and their associated vasculature. Since then, research has been conducted to 
understand ovarian anatomy, physiology (i.e., follicle development, luteal function, menstrual 
cyclicity), pathophysiology (i.e., ovarian tumors, endometriosis, polycystic ovary syndrome), as 
well as the hormonal and non-hormonal control of reproduction during the use of contraception 
or assisted reproduction. 
1.1.2 Anatomy of the Ovary 
The human ovaries are two oval shaped organs located in the lower abdomen, posterior to 
the bladder and anterior to the rectum. The ovaries are attached to the uterus below the cornua 
(i.e., uterine horn) via the proper ovarian ligament and to the pelvic walls by the suspensory 
ligaments [4]. The ovaries are about 3 cm long, 2 cm wide and 1.5 cm thick [5]. The internal 
anatomy of the human ovary is shown in Figure 1.1. The ovary is divided into the outer cortex 
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and the inner medulla, which are collectively referred to as the stroma [6, 7]. The stroma is 
composed of connective tissue, blood vessels and nervous tissues that permeate both the medulla 
and cortex.  The cortex which constitutes the majority of the ovary contains the follicles and CL 
[8]. Follicles, at various developmental stages, may be present on a given day during the 
menstrual cycle (described later). In general, a mature follicle is enclosed by a wall consisting of 
theca and granulosa cell layers which encapsulates a fluid-filled cavity (referred to as the 
antrum). The oocyte is surrounded by a specialized layer of granulosa cells (termed the cumulous 
oophorus), and is attached to the follicle wall [7].  The medulla contains numerous blood and 
lymph vessels that branch out into the cortex to supply the growing follicles and CL [6, 7, 9]. 
The ovarian cortex is enclosed by a dense connective tissue known as the tunica albuginea [3, 6, 
7]. The surface or germinal epithelium is present on the surface of the ovary (i.e., above the 
tunica albuginea) and is composed a single layer of cuboidal or columnar epithelium [3, 7]. 
The functioning of the ovary is maintained by its vasculature, innervation and lymphatic 
circulation. The ovarian artery, branching from the abdominal aorta, enters the ovary at the hilum 
and provides the primary blood supply to the ovary [4, 10]. The left and right ovarian veins lie 
parallel to the arterial system and drain into the renal vein and inferior vena cava, respectively [4, 
11]. Antral follicles contain a capillary network in the theca cell layer of the follicular wall that 
promotes follicular growth [8, 12, 13]. The granulosa cell layer is considered avascular until after 
ovulation or during atresia [11]. Ovarian vasculature plays a crucial role in follicle growth, 
ovulation and luteal development [12, 14]. Ovarian innervation arises superiorly from the 
intermesenteric nerves and renal plexus, intermediately from the hypogastric nerve, and 
inferiorly from the pelvic plexus [15]. The majority of the nerves of the ovary are adrenergic 
with the main neurotransmitter being noradrenaline [8, 11]. The extrinsic nerves enter the ovary 
through the hilar perivascular plexus and regulate blood flow [16-18]. The lymphatic vessels run 
along the surface of the ovary and also line the outside of growing follicles [11]. The lymph 
vessels in the ovary excrete unnecessary hormones and tissue debris [19].  
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Figure 1.1: Anatomy of the human ovary. (Basnayaka, et al., 2013, unpublished) 
 
1.1.3 Human Ovarian Physiology 
1.1.3.1 Pre-Antral Folliculogenesis 
The development of ovarian follicles occurs in four stages throughout a woman’s 
menstrual cycle. During the earliest stage, the follicles are termed primordial follicles. A 
primordial follicle contains a primary oocyte (25 µm in diameter) which is surrounded by a 
single layer of squamous follicular cells [7, 8, 20]. The primary oocyte is arrested at prophase I 
of meiosis until ovulation and contains of a large, asymmetrically placed nucleus and a 
homogeneous cytoplasm [7, 21-23]. Primordial follicle growth is characterized by an increase in 
oocyte size as well as the growth and proliferation of follicular cells, the granulosa and theca 
cells [7]. A primary follicle develops in the second stage of follicle growth and is characterized 
by a multilayered arrangement of cuboidal  granulosa cells around the oocyte [7, 24]. During the 
third stage of follicular growth, theca interna and theca externa cell layers form within the 
follicle wall to form secondary follicles [22]. The theca interna cell layer is highly-vascular and 
contains cuboidal-shaped steroidal secretory cells, fibroblasts, and collagen bundles [7, 21, 22, 
25-27]. The connective tissue cells of the theca externa are spindle-shaped and surrounded by 
collagen fibers and some smooth muscle [7, 25, 27]. A thin basement membrane separates the 
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theca interna and externa cell layers from the granulosa cells [21, 22, 25, 28]. Secondary follicles 
undergo major changes during the late tertiary stage of follicular development, including 
expansion of the oocyte to about 120 µm, development of inner cellular components (i.e. 
mitochondria, endoplasmic reticulum, and golgi complexes), and the formation of a zona 
pellucida [7]. The zona pellucida is an extracellular matrix containing glycoproteins that 
surround the oocyte [6-8].  
Pre-antral follicle development occurs independent of gonadotropins, FSH and LH, and is 
regulated by paracrine and autocrine stimuli, such as growth factors [29]. Hormonal and non-
hormonal regulation of follicular development is not the focus of this thesis and is therefore not 
reviewed in detail.  
1.1.3.2 Antral Ovarian Folliculogenesis 
An antral cavity will begin forming inside the follicles when they are 0.2 mm in diameter 
[30]. Tertiary follicles develop during the fourth stage of development [6, 8, 9, 31]. Tertiary 
follicles are also referred to as Graafian follicles. The total diameter of a tertiary follicle ranges 
from 8-30 mm in diameter [6, 31]. The antrum is filled with follicular fluid which contains 
growth factors, hyaluronate, plasminogen, fibrinogen, anticoagulants, and steroids that provide a 
nourishing environment for the growth of the oocyte [7, 8]. The granulosa cell layer 
differentiates into two separate components: the mural granulosa cells of the follicular wall, and 
the cumulus oophorus (i.e., cells that aggregate around the oocyte), [6, 7, 31]. The cumulus 
oophorus and oocyte are collectively known as the cumulus-oocyte complex (COC) [8].  
The final stage of follicle development involves the cyclic formation of antral follicles 
throughout the menstrual cycle [32]. The human menstrual cycle begins at the time of menarche 
(i.e., 8.5 – 13 years) and lasts until menopause (i.e., approximately 51 years) [33, 34]. The 
menstrual cycle in women is divided into two main phases: (1) follicular phase and (2) luteal 
phase. The average menstrual cycle occurs over 26 – 35 days [35]. The follicular and luteal 
phases of a woman’s menstrual cycle can vary from 10-23 days and 8-17 days, respectively [36]. 
Antral ovarian follicles develop in either 2 or 3 waves during a woman’s menstrual cycle [32, 
37-39]. Each antral follicle wave of the cycle may also be referred to as a “recruited cohort” [37, 
38]. The wave-model for follicular development in reproductive age women is similar to that of 
cows and mares, where the final wave of the interovulatory interval (IOI) is ovulatory and all 
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preceding waves of the IOI are anovulatory [5, 37, 40]. Major waves are those in which a 
dominant follicle is preferentially selected for growth [40]. Minor waves are characterized by the 
absence of a dominant follicle [40]. Therefore, the final ‘ovulatory’ wave of the IOI is major, 
while the anovulatory waves which precede the ovulatory wave may be major or minor.  
Emergence of the first follicular wave of the menstrual cycle occurs at a diameter of 
approximately 4 - 5 mm, and selection of the dominant follicle occurs at a diameter of 
approximately 10 mm [38]. The dominant follicle is a tertiary follicle with a diameter of 20 mm 
prior to ovulation [7, 8, 31]. Graafian follicles prior to ovulation contain a serrated granulosa cell 
layer and a fragmented basal lamina [21]. 
FSH levels rise during the late-luteal-early follicular phase to induce emergence of a 
follicular wave [41]. Inhibin B production from follicles of the recruited cohort or wave  act to 
suppress FSH concentrations [42]. At the time of selection of the dominant follicle in the mid-
follicular phase, FSH is low and estradiol gradually increases. At the time of selection,  there is 
also a transition from inhibin B to inhibin A production and a shift from FSH to LH 
responsiveness [41]. Increased estradiol levels from the developing follicles during the follicular 
phase  stimulates the growth of the endometrial lining to prepare for a potential pregnancy [43]. 
Pre-ovulatory surges in LH and FSH occur at the end of the follicular phase in response to 
positive feedback from dominant follicle estradiol production [37]. The rise in both FSH and LH 
occur approximately 24 hours after the surge in estradiol [21]. Ovulation occurs approximately 
36 to 40 hours following the LH surge [44]. In some women, the first wave of the follicular 
phase is anovulatory and a second wave develops in the mid-follicular phase to result in 
ovulation. A second rise in FSH has been  associated with emergence of the second follicular 
wave [38].  
The pre-ovulatory FSH surge induces another wave of follicle development in the early 
luteal phase, at which time the CL is developing. By the mid-luteal phase, LH and FSH are low 
while progesterone and estradiol concentrations reach peak concentrations [37, 45]. The 
regression of the CL in the late-luteal stage is marked by a decrease in both progesterone and 
estradiol concentrations and a subsequent rise in FSH [45]. The loss of progesterone and 
estradiol leads to the shedding of the endometrium [35]. With the rise in FSH, a new wave 
emerges and the follicular phase of the next menstrual cycle is initiated [35, 37].  
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1.1.3.3 Ovulation   
Ovulation is the process by which the oocyte is released from the ovarian follicle. The 
pre-ovulatory LH surge induces a series of morphologic and physiologic changes in the follicle 
and oocyte. Morphological changes include the expansion of the cumulus, increased blood 
supply to the theca intern, folding of the granulosa cell layer and fragmentation of the basal 
lamina [8, 21]. One of the most conspicuous indications of imminent ovulation is the cone-like 
stigma that forms on the surface of the follicle wall [8, 46]. The oocyte becomes detached from 
the Graafian follicle wall approximately 25 minutes prior to ovulation [47]. An inflammatory 
process stimulates the degradation and rupture of the follicle wall under a steady intrafollicular 
pressure [46]. Following the LH surge, the oocyte completes the first meiotic division and the 
first polar body is released [48]. The oocyte that is ovulated is therefore in the metaphase II stage 
of meiotic development [44]. The COC along with the antral fluid is released into the peritoneal 
cavity towards the fimbria of the fallopian tube [7, 8, 48]. The time required for ovulation is 
highly variable, but on average, occurs within 10 minutes [49]. Following ovulation, the 
remaining cells of the follicular wall undergo vascular and endocrinological changes to form the 
CL [45, 50, 51] 
1.1.3.4 Luteogenesis and Luteolysis 
The CL is composed of endothelial cells and luteinized theca and granulosa cells as well 
as immune and fibroblast cells [7, 8, 50, 52]. Granulosa-lutein cells are modified granulosa cells 
[22, 53]. Theca-lutein cells are modified theca cells located on the periphery of the CL [22, 53]. 
Compared to granulosa-lutein cells, theca-lutein cells contain more lipid droplets and are more 
abundant in the CL [53]. The luteal structure is known as a corpus hemorrhagicum when blood 
accumulates inside the  cavity during and/or following follicle rupture [54]. Peak luteal diameter 
and optimal blood flow to the CL is observed 7 days after ovulation [55]. The mature CL is 25-
40 mm in diameter and appears yellow [52, 54]. The term ‘corpus luteum’ is Latin for “yellow 
body”. The CL functions as a temporary endocrine gland as it is the main source of steroid 
hormones (i.e., progesterone and estradiol) during early pregnancy [7, 50].  
If conception occurs, the CL increases in size until approximately the 12th week of 
gestation, at which time the placenta has formed to maintain the pregnancy [56]. In the absence 
of conception, the CL begins to regress approximately 7 days post-ovulation [7, 8, 52]. 
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Luteolysis is associated with a decline in progesterone concentration, as well as apoptosis and 
tissue involution [8]. The regressing CL is referred to as the corpus albicans (CA), which is Latin 
for ‘white body’ [7]. The CA appears as a small mass of amorphous scar tissue that may persist 
in the ovary for several months post-ovulation [56].  
 
1.1.3.5 Follicular Atresia 
The number of follicles within the human ovary is constantly changing. Women are born 
with approximately 2 million resting follicles, but only hundreds of follicles remain at the time of 
menopause  [57]. Approximately 400-500 follicles will ovulate during a women’s lifetime, if she 
is not pregnant or taking oral contraceptives [7, 8, 58]. Follicular regression or ‘atresia’ is a 
physiologically-normal phenomenon that occurs throughout a woman’s lifetime. The rate of 
atresia is thought to be about 1000 follicles per menstrual cycle [59]; more than 90% of follicles 
are destined for atresia throughout a woman’s lifetime.  Follicle atresia begins at the 24th week of 
gestation and is influenced by factors such as health, age, stage of follicular development, 
environmental factors, and genetics [21, 57, 60, 61]. Atretic changes in the granulosa cells 
precede oocyte degeneration [28, 62, 63]. Granulosa cells near the antrum develop pyknotic 
nuclei and are shed into the antral cavity; the remaining granulosa cells undergo nuclear 
condensation and are phagocytosed [27, 60]. Other changes that indicate follicular atresia are 
reduced translucency and an increased androgen to estrogen ratio in the follicular antrum [21]. 
Later stages of follicular atresia are characterized by the development of apoptotic bodies and 
cytoplasmic droplets in granulosa cells, hypertrophied theca interna cells, and a hyalanized zona 
pellucida [21, 27]. The separation of the COC and disintegration of cellular organelles are also 
apparent [21, 64]. Macrophages and neutrophils eventually invade the atretic follicles and 
remove debris from the ovary [21]. Factors known to promote atresia include hyophysectomy, 
antibodies to gonadotrophins, ligation of the ovarian artery, exposure to environmental 
contaminants, and smoking [21, 65].  
The number of pre-antral follicles within the ovaries is referred to as the ovarian reserve. 
With age, follicular atresia and to a lesser degree ovulation, lead to a continued depletion of the 
ovarian reserve. Menopause refers to the stage of a woman’s cycle when menstruation ceases 
[30]. The number of antral follicles (Antral Follicle Count, AFC) that can be visualized 
ultrasonographically has been shown to be a marker of the ovarian reserve [37, 66, 67]. AFC is 
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used to predict the ovarian response to assisted reproductive therapy. AFC is also used to predict 
the timing of the onset of menopause [68-71].   
1.1.3.6 Aging and Ovarian Function 
Follicular wave dynamics change as women approach menopause. It has been shown that 
as women age, luteal phase dominant follicles emerge earlier relative to ovulation, grow larger 
and for a longer period of time compared to women of reproductive age [72]. 
The ovary of a postmenopausal woman is smaller in weight and volume and shriveled in 
appearance compared to a younger ovary due to the depletion of follicles [8, 73]. Preovulatory 
oocytes in the aging ovary are more likely to contain cellular and chromosomal defects [74]. The 
aging ovary is associated with the development of excess fibrous connective and scar tissues in 
the ovarian stroma [8]. An overall reduction in blood flow to the ovary related to reduced 
vascular network and thickened vessel walls are also observed in aging ovaries [8]. The surface 
epithelium of the ovary in older women contains fewer and flatter cells with shorter microvilli 
[8]. Smoking has been found to be an environmental factor that accelerates aging of the ovary by 
inducing follicular apoptosis through intrafollicular oxidative stress [8, 75]. These age-related 
changes in the ovary can hinder oocyte development and thereby compromise pregnancy 
outcomes. 
 
1.2 The Bovine Ovary 
1.2.1 The Bovine Model for Studying Human Ovaries 
The conduct of human reproductive studies is often challenged by ethical limitations. As 
a result, the bovine species has been established as a model to study ovarian anatomy and 
physiology in women of reproductive age, advanced reproductive age, and those undergoing 
assisted reproduction [5, 37, 38, 76]. Both human and bovine species are monovular and 
polycyclic [5]. Physical characteristics of cow ovaries are similar to human ovaries, including 
size (i.e., 3 x 2 x 1.5 cm). Furthermore,  the growth dynamics of follicles and CL are similar 
between species [5]. Pathological conditions, such as follicular cysts and luteinized anovulatory 
follicles, are also observed in both bovine and human species [5]. Research in both cows [77] 
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and women [78] have shown that quantitative ultrasonographic image analyses of follicles and 
CL corresponds with their physiological status.  
1.2.2 Estrus versus Menstrual Cycle 
In cows, the reproductive cycle is based on “estrus”, the period of increased sexual 
receptivity that occurs prior to ovulation [37]. The estrus cycle lasts for an average of 21 days 
and is divided into four mains stages: (i) proestrus, (ii) estrus, (iii) metestrus, and (iv) diestrus 
[79-81].  The proestrus and estrus stages are collectively referred to as the follicular phase [82]. 
Likewise, the metestrus and diestrus phases are known as the luteal phase [82]. The follicular 
and luteal phases of cows consist of 3-4 days and 16-18 days, respectively [37]. Ovulation and 
behavioral patterns indicative of sexual receptivity (i.e., heat and vaginal discharge) occurs 
during the estrus phase [80, 82]. Signs of sexual receptiveness have also been observed in 
humans but are less obvious compared to cows [83]. 
Endocrinologic changes during the estrus cycle are generally consistent with those during 
the human menstrual cycle [37]. Proestrus is marked by the regression of the CL and the 
development of the preovulatory follicle [80]. Proestrus and estrus stages include decreased 
progesterone from the CL and an increase in estradiol from the follicle [79, 80, 82]. Dominant 
follicle estradiol production leads to pre-ovulatory surges in LH and FSH [79, 82]. The metestrus 
stage includes the formation of the CL and progesterone secretion after ovulation [82]. Metestrus 
uterine bleeding, associated with the increasing progesterone-to-estradiol ratio, occurs in 48-60% 
of cows [84]. During the diestrus period, the CL becomes fully-functional and secretes high 
levels of progesterone [79, 82].  Early structural and functional regression of the CL occurs 
during late diestrus stage in the absence of pregnancy [80]. Luteal regression and a 
corresponding decline in progesterone occur earlier (i.e., mid-luteal phase) in women compared 
to the bovine species (i.e., late-follicular phase) [45]. 
 
1.3 Ovarian Imaging Techniques 
The development of medical imaging techniques has contributed immensely to the 
understanding of reproductive anatomy and physiology, and enhanced clinical diagnoses. This 
chapter focuses on early, conventional, and emerging methods of ovarian tissues imaging.  
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1.3.1 Histological Imaging  
Histologic evaluation of the ovaries was first conducted in 1951, and is currently the most 
common method used to diagnose ovarian pathology ex vivo [85, 86]. Histological evaluation of 
ovarian tissues typically involves fixing the tissues of interest in formalin and embedding them in 
paraffin. Fresh tissues require fixation to preserve cell structures and prevent post-mortem 
changes such as putrefaction and autolysis [87, 88]. The classic fixative for most soft tissues, 
including ovaries, is 10% neutral buffered formalin, consisting of formaldehyde (primary 
fixative) and methanol (coagulative fixative) [26, 87, 89-91]. The purpose of fixation is to 
stabilize chemical bonds within the living cells prior to tissue processing [26]. Inadequate 
fixation can result in cellular changes within the tissues, including a disruption of the 
mitochondrial matrix and smooth endoplasmic reticulum [87]. Prolonged fixation using 
formaldehyde can also cause shrinkage of the tissues [92]. Following fixation, the tissues are 
sectioned at 3 to 4 mm in thickness and placed in embedding cassettes [26]. Tissue processing 
begins by dehydrating the tissue sections using alcohol [22, 26, 91]. The dehydrated tissues are 
then treated with a clearing agent, such as xylene, chloroform, or toluene [26, 88]. Infiltration is 
a process by which paraffin is infused into the tissue [22, 26, 88, 91]. The infiltrated tissues are 
then embedded into melted paraffin and allowed to solidify [22, 26, 88, 91]. Embedding creates 
solid paraffin blocks of the tissue samples for microsectioning [22, 26]. Microsectioning involves 
slicing the prepared tissue paraffin blocks into very thin sections using a microtome. Selected 
slices of the tissue sample are then placed on a warm water-bath prior to transferring them onto a 
microscope slide. The water-bath helps to smooth out wrinkles or folds in the sections [88]. The 
microscopic slides with the tissue sections are placed on a heating block overnight [26, 88].  
Staining the prepared slides involve a series of steps, beginning with deparaffinization 
using xylene or toluene [26, 88]. The slides are then dipped in a series of alcohol solutions [26]. 
The sections are hydrated and then stained with hematoxylin and eosin. [26, 88]. The slides are 
rinsed in running water to remove excess stain and dipped into 1% hydrochloric acid in 70% 
ethanol until a brown color appears [26].  The slides are washed again in water, soaked in 0.5 % 
eosin, and then dipped through a series of alcohol baths [26]. The last steps of the staining 
process include washing the slides with xylene and mounting the coverslips. Staining is used to 
differentiate structural components of biological tissues. Hematoxylin is a base that stains the 
acidic portions of a cell (i.e., nucleus and ribosome-rich regions of the cytoplasm) with a bluish 
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color [88, 91]. Eosin is an acid that stains basic components of the tissues (i.e., cytoplasm) with a 
reddish tint [88, 91]. An example of a histological photograph of a bovine ovary is shown in 
Figure 1.2. One of the common problems in histology is over or under-staining, which can 
interfere with the microscopic analysis of the slides.  
Histology is a useful technique for identifying structures within an organ, diagnosing 
lesions, and detecting parasites or regions of degenerations and regeneration [92]. The earliest  
histological ovarian evaluations were conducted in the 1950s [85, 86].  These studies involved 
the development of a classification system for ovarian follicles, comparison of growth and 
degeneration of follicles in the ovary, and variations in follicle growth in women of different 
ages [85, 86]. Histology can only be performed after surgical removal of the ovaries or post-
mortem. Therefore, histology does not enable the real-time investigation of ovarian structures 
across the menstrual cycle. Histological techniques also do not allow the evaluation of fluid 
volume within a cavity (i.e., follicle), direction or amount of blood flow within the tissues, as 
well as cellular interactions [92]. Despite these limitations, histology has become the gold 
standard for pathological evaluations because of its ability to visualize tissues at the cellular 
level.  
 
 
 
 
Figure 1.2 A histological photograph of a bovine ovary sectioned at 10 µm and stained with 
hematoxylin and eosin. (Basnayaka, et al., 2013, unpublished) 
 
1.3.2 Ultrasonographic Imaging 
Ultrasonography was first used in 1914, during the First World War, as a method for 
detecting submarines. Ultrasonography was first introduced to the field of medicine during the 
late 1940s [93, 94]. Alfred Kratochwil was the first person to obtain a clear ultrasonographic 
image of the human ovary [93]. He demonstrated that morphological changes in the ovary 
including luteal development and regression, can be detected with ultrasonography [93]. Since 
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then, ultrasonographic imaging has become the most commonly-used tool for real-time 
examination of anatomical and physiological changes in the female pelvis [95]. Diagnostic 
ultrasonographic imaging systems are easily accessible, user-friendly, non-invasive, inexpensive, 
and portable [96, 97].  
 In ultrasonography, sound waves are created by vibrations of crystals [97].  The crystals 
are piezoelectric and can thereby produce mechanical sound waves from an electric current [98, 
99]. Ultrasound is a sound wave with a frequency above the audible range of hearing (20 Hz – 20 
kHz) [100]. Sound is a longitudinal wave, meaning that the vibrations oscillate back and forth 
along the direction of propagation of the wave [100]. The frequency range of sound waves for 
medical diagnostic imaging is  2-15 MHz [100]. Once the sound waves are transmitted into the 
tissues, they can be either reflected, scattered or refracted [98, 99].  Acoustic impedance 
describes the inherent characteristic of a certain medium to propagate sound waves [99, 100]. 
Reflection of sound waves occurs at large interfaces (i.e., between organs) when the difference in 
acoustic impedance is high. The sound wave is scattered when it encounters objects that are 
equal or smaller than the wavelength [100].  A low acoustic impedance difference between 
tissues borders indicates less reflection, more refraction, and more transmission of the sound 
waves [99]. In contrast, a high acoustic impedance between tissues leads to the loss in energy of 
the sound wave as it travels through tissue which is also known as attenuation [100, 101]. 
Attenuation is influenced mostly by absorption of energy into the tissues, as well as some 
scattering [101, 102]. Only the reflected and scattered sound waves will return back to the 
transducer. The returned ultrasound wave is converted into an electric signal and displayed on 
the imaging monitor [101]. Sound waves that are refracted can sometimes produce echoes that 
are detected in an ultrasonographic image. However, the refracted echo is displayed as 
originating from an undeviated axis and is misplaced from its original position in the 
ultrasonographic image [103].   
1.3.2.1 Generation of Ultrasonographic Images 
 The overall process of ultrasonographic imaging is shown in Figure 1.3. The mechanical 
signal of the returning sound wave is detected by a receiver. Upon receipt, the signal is amplified 
to compensate for attenuation [98]. The strength or amplitude of the returning signal at regular 
intervals in time is measured [98, 103]. A digital scan converter converts the mechanical echo 
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signal into a digital electrical signal which is  stored as binary digits, or ‘bits’[103]. Each bit is 
assigned a gray-scale value corresponding to the amplitude of the returning signal, which is 
displayed on the imaging monitor [103]. The echoes are stored in vertical scan lines and then 
read by the scan converter as horizontal or raster lines [103]. A picture element or ‘pixel’ is 
located at the intersection of a scan and raster line. After an ultrasound pulse is emitted, B-mode 
(Brightness mode) imaging displays the brightness of pixels, which corresponds to the amplitude 
of the signal [101, 104]. Each pixel represents one of the 256 shades of gray. The location of 
each pixel depends on the location of the stored digital signal in the scan converter, [103]. 
Digitized ultrasound signals are less prone to noise, and allow real-time scanning and stable post-
processing of the images [103, 105]. Real-time B-mode imaging is the most commonly-used 
form of ultrasonographic imaging [97]. Fluids (i.e., follicular fluid) are considered non-reflective 
or ‘anechoic’ and  appear black in the ultrasonographic image [98]. In contrast, highly dense 
structures, such as bone and calcifications, are reflective, and are displayed as white or 
‘hyperechoic’ foci in the images [98]. Tissue structures that appear as darker shades of gray in 
the ultrasonographic image are considered hypoechoic. 
 Other types of ultrasonographic imaging include Amplitude (A)-mode, Motion (M)-
mode, and Doppler. A-mode imaging displays the amplitude or the strength of the reflected 
signal with imaging depth [101]. A-mode imaging was one of the earliest types of 
ultrasonography, and is no longer used. M-mode imaging is currently used to evaluate structural 
movement with time (i.e., cardiac function) [101]. Doppler imaging is used to detect 
characteristics of blood flow, such as speed and direction [97, 101].    
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Figure 1.3 Basic processes of conventional ultrasonographic imaging. (Basnayaka, et al., 2013, 
unpublished) 
 
1.3.2.2 Ultrasonographic Imaging of the Ovaries 
Ultrasonographic imaging of ovaries can be achieved transabdominally (3 – 5 MHz) or 
transvaginally (5 – 7.5 MHz) in women. Furthermore, transrectal ultrasonography is often 
conducted (7.5 – 10 MHz) in animals [106, 107]. Transabdominal scanning was the first type of 
imaging adopted for diagnostic purposes. Transabdominal imaging for evaluating the ovaries 
involves placing the transducer directly above the symphysis pubis [96, 107]. A full bladder can 
improve the visualization of the ovaries [107]. In contrast, transvaginal or transrectal approaches 
offer improved resolution of the ovaries because of the close proximity of the transducer to the 
target tissues [96]. Filling of the urinary bladder is not necessary for the transrectal or 
transvaginal methods [96].  Transvaginal ultrasonography is now the preferred imaging modality 
for evaluating the ovaries in women. The advent of transvaginal ultrasonography has 
substantially improved the ability to visualize normal and abnormal morphology of the ovary. It 
has been found that ultrasonographic image attributes of ovaries correspond to structural, 
functional and haemodynamic changes [45, 77].  
 
1.3.2.3 Artifacts and Limitations of Ultrasonographic Imaging 
 The ability of ultrasonography to resolve structures within biological tissues (i.e., ovaries) 
is determined by axial, lateral, and elevation resolution. Axial resolution describes the ability to 
distinguish between two tissue reflectors that are along the beam axis while lateral resolution 
Post-
Processing 
     
Transmitter 
(Output) 
Receiver/ 
Amplitude 
Processing 
Scan 
Converter Memory Transducer/Probe 
Sample 
Final Image 
15 
describes the ability to resolve 2 reflectors  positioned perpendicular to the beam axis [101, 102]. 
Axial resolution is based on the wavelength and the number of wave cycles emitted per 
transmitted pulse [108]. Therefore, the axial resolution can be improved by increasing the 
imaging frequency [102]. Lateral resolution is dependent on the width of the piezoelectric 
elements, and can be optimized by focusing the beam [109].  Elevation resolution is based on the 
ultrasound beam thickness perpendicular to the scan plane [110].   
Ultrasonographic images are subject to artifacts, which are added, removed or misplaced 
echoes that decrease image quality [101, 110]. Artifacts are primarily caused by variations in the 
tissue structure and/or the mechanics of the transducer [101]. Understanding the mechanisms 
underlying common artifacts is essential for accurately interpreting ultrasonographic images. 
Reverberation artifacts are formed when a sound wave encounters two interfaces with a high 
mismatch in acoustic impedances [102]. Shadowing and reverberations are the most common 
artifacts that are visualized during imaging of the pelvis [96]. Reverberations are caused by the 
reflection of sound waves by strong reflecting interfaces, such as liquid-filled areas [110]. 
Reverberations can be identified as a series of parallel lines of decreasing brightness in the 
ultrasonographic image [96, 101, 110]. Shadowing is created by structures that have strong 
attenuation, such as bowel, which creates a dark shadow posterior to the structure [96, 99, 102, 
110]. Enhancement artifacts are created when the transmitted wave encounters structures with 
poor attenuation, such as fluid-filled structures in the ovary [96, 110]. Enhancement produces a 
bright signal in the image area that is distal to the fluid-filled structure [44, 96, 110].  
Ultrasonography has most certainly increased our understanding of ovarian structure and 
function over the past 30 years. However, it is worthwhile to recognize that the resolution of 
standard routine ultrasonography limits the visualization of ovarian structures < 2mm in diameter 
such as early antral follicles and COC. Another limitation associated with ultrasonography is the 
difficulty in visualizing tissues that lie deep within the body, a  particular concern in women with 
a large body habitus [96, 111]. Furthermore, the presence of air-filled bowel can impede sound 
wave transmission and interfere with image quality [96]. Ultrasonography does not emit 
radiation, but some of the ultrasound energy can be lost as heat into the tissues [112]. 
Furthermore, ultrasound waves transmitted at high frequencies for long periods of time can cause 
the generation of gas bubbles within the body (i.e., cavitation), which may cause health concerns. 
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Appropriate actions must be taken by the ultrasonographer to minimize patient risk by 
optimizing and maintaining equipment according to the current safety standards [112]. 
1.3.3 Synchrotron Imaging 
Radiation-based medical imaging was first used in 1895, after the discovery of X-rays by 
Wilhelm Röntgen (Germany) [113, 114].  X-rays are electromagnetic, transverse, waves 
containing photons which range in energy from 0.1 to 150 keV [115, 116]. The corresponding X-
ray wavelength is about 0.01 to 10 nm [116, 117]. Synchrotron imaging is a novel X-ray 
technique in which a high-energy light beam is generated. Synchrotron-based visible radiation 
was first created in 1947 by General Electric [118]. Since then, more than 70 synchrotron 
facilities have been established worldwide and numerous studies have been conducted to 
optimize synchrotron methods for biomedical imaging.  
In a synchrotron, electrons are injected into a vacuum-sealed tube and are accelerated to 
reach very high speeds and energy states [119]. The accelerated electrons are stored in a 
centrally-located, closed-loop tube, known as the storage ring [120]. A series of ‘bending’ 
magnets are placed along the storage ring to maneuver the beam in a circular direction [119, 
120]. In the storage ring, the electrons will emit electromagnetic radiation (i.e., synchrotron 
radiation or light) when their trajectories are bent by a magnetic field [119, 120]. The production 
of synchrotron light is governed by inverse Compton scattering [119]. During inverse Compton 
scattering, an electron collides with an incoming photon and loses energy while emitting another 
photon of higher energy [119]. In the synchrotron, the storage ring consists of a static magnetic 
field which acts as an incoming virtual photon with which the electrons collide and generate 
synchrotron light [119]. The light that is emitted can be directed along tangential straight tubes or 
beamlines, which can then be used for conducting experiments with various applications [120]. 
An important characteristic of a synchrotron is that the electrons circulate around the storage ring 
in discrete bunches [120]. Therefore, synchrotron light is emitted as a pulse rather than a 
continuous form. The synchrotron consists of a radiofrequency cavity which accelerates the 
electric field to compensate for the loss of energy in the electron beam as waves are emitted 
[119].  Insertion devices can be placed along the electron pathway to optimize radiation 
characteristics, such as energy and bandwidth [119].  
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X-rays that enter an object can lose energy or become attenuated through photoelectric 
absorption and Compton scattering (i.e., inelastic scattering). Photoelectric Absorption is the 
absorption of the incident X-ray by tissue, which results in a loss in beam energy as it travels 
through an object [121]. Compton scattering arises when the X-rays encounter small objects 
within the tissues that redirect the photons from the original direction of the beam [121, 122]. 
The redirected photon will contain a lower energy than the incoming photon [116]. Both 
photoelectric absorption and Compton scattering primarily exist in the X-ray medical imaging 
range of 20 to 150 keV [121, 123].      
Other X-ray interactions that play an important role in medical imaging include 
refraction, coherent scattering (i.e., elastic scattering), and diffraction. Refraction is the 
transverse shift of the beam direction as the X-rays propagate through media [124]. Coherent 
scattering is similar to Compton scattering but results only in a change in direction of the 
scattered photon and therefore does not contribute to attenuation [123]. Diffraction occurs due to 
the interference of coherently scattered X-rays by a solid object, such as a crystal [113].  
In conventional radiology, only the X-ray absorption in the object is used for biomedical 
imaging [125, 126]. Conventional X-rays will therefore have to be powerful enough to provide 
enough signal to be absorbed to visualize objects, but also maintain low radiation exposure to the 
tissues [120]. Alternatively, the synchrotron offers the possibility of imaging biological tissues 
with various techniques that do not rely only on absorption of X-ray characteristics, which 
translates to lower radiation exposure to the patient.  
Advantages of using synchrotron radiation for biomedical imaging include the 
availability of an X-ray beam that is polarized, collimated, high intensity and tunable over a wide 
energy spectrum ranging from infrared to hard x-rays [120, 127]. One of the biggest limitations 
of conventional radiographic imaging of biological tissues is radiation damage to the tissues. 
Irradiation of biological tissues may disrupt cell division and induce cell death [116]. Radiation 
doses less than 50 mSv is considered to be safe and do not cause any observable physiological 
damage to tissues [128]. A crystal monochromator is used at the synchrotron to select a specific 
wavelength of energy which allows samples to be imaged with less radiation exposure compared 
to conventional radiography [113].      
Synchrotron imaging has been used to examine physical (i.e., density, morphology) and 
chemical (i.e., state and structure) properties of biological tissues [129]. The synchrotron has 
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been adapted as a tool to examine feeding patterns in beetles and butterflies [128], lung function 
in mice and rabbits [124, 130, 131] as well as respiratory function in grasshoppers [132]. 
Researchers have also examined synchrotron radiation angiography in rabbits [133], mice [134], 
dogs [135], pigs [136] and humans [137]. Synchrotron technologies have provided improved 
resolution for differentiating normal and abnormal breast tissue, compared to conventional 
mammography [138-141]. The synchrotron can be used to image renal and prostate tissue [142]. 
Synchrotron technologies also show promise as a source of radiotherapy for patients [143]. The 
high collimation of synchrotron X-rays can improve tissue targetability and decrease radiation 
exposure to patients [143]. 
A few reproductive imaging studies have been conducted using the synchrotron. A proof-
of-principle study was conducted  by members of our research group in 2002 to examine the 
usefulness of early synchrotron techniques for imaging  bovine ovaries [144]. Synchrotron-based 
high resolution X-ray computed microtomography has also been used to image genital 
morphology of caecilian amphibians [145] and reproductive organs of mites [146]. In addition, 
synchrotron imaging has been used to examine the molecular architecture and elemental 
composition of mice oocytes in vitro [147, 148] as well as mammalian oocyte coat assembly and 
oocyte-sperm interactions [149].  
1.3.3.1 Phase-Contrast Based Imaging Techniques 
 Phase-contrast based synchrotron techniques are emerging as novel approaches to 
biomedical imaging. Contrast is the difference in brightness between image pixels [116]. The 
contrast in the images obtained using phase-contrast techniques is derived from the refraction 
and absorption properties of tissues, such as tissue thickness and density [113, 123-125, 138, 
150]. There are three main phase-contrast imaging techniques:  
(1) Analyzer-based or Diffraction Enhanced Imaging (DEI); 
(2) Propagation-Based Imaging (PBI); and  
(3) Talbot Grating Interferometry (TGI).  
The main setup of the beamline for the three different phase contrast-based techniques 
compared to absorption imaging (i.e., conventional radiography) is shown in Figure 1.4. 
Beamline components include a monochromator, sample stage, and a detector (Fig.1.4 A - D). 
The monochromator consist of two crystals, which allow the selection of a very narrow band of 
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wavelengths [119, 120]. The main purpose of the detector is to convert the detected photons into 
an electronic signal that is suitable for digitalization [120]. However, the mechanism by which 
the conversion occurs can vary according to the type of detector. Two common types of detectors 
are ionization chambers and CCD (i.e., charged coupled device) detectors. The current signals in 
the ionization chambers are directly created by the interaction of gas molecules with incoming 
photons [120]. Charged coupled devices will generate electrical charge through the sequential 
movement of photons through a series of bins [120]. The resulting electrical signal will be 
converted into a digital bit stream by an analog-to-digital converter [116].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Synchrotron beamline setup for absorption imaging (A) and phase-contrast 
techniques, including Propagation-Based Imaging (B), Diffraction Enhanced Imaging (C), and 
Talbot Grating Interferometry (D). The direction of the synchrotron light beam and the scattering 
of the X-rays are also indicated. (Basnayaka, et al., 2013, unpublished) 
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1.3.3.1.1 Diffraction Enhanced Imaging (DEI) 
DEI involves the placement of a crystal, referred to as an analyzer, between the sample 
and detector (Figure 1.4C) [151]. The analyzer is rotated at various positions on a curve (known 
as the ‘rocking curve’) which allows the investigator to measure relative energy intensity as a 
function of the angular position of the crystal [152, 153]. Only X-rays that are selectively 
accepted by the crystal will be diffracted and detected in the final image [152]. Images obtained 
with DEI contain contrast information based on the absorption, refraction and scatter rejection of 
X-rays [152]. The crystal acts as an anti-scatter device as it removes most of the X-rays that are 
scattered from the sample [123]. ‘Apparent absorption’ images contain contrast based on 
absorption and scattering of X-rays [141, 154]. The crystal analyzer is placed at the top of the 
rocking curve to obtain an absorption image that is nearly free from scatter [154]. Refraction 
images obtained with DEI will only contain refracted contrast from the sample [152]. DEI has 
been useful for detecting boundaries and edges of samples, as well as changes in the refractive 
indices between materials [152]. Studies have been conducted to examine DEI as a tool for  
evaluating human samples, including bone and soft tissues of the foot and ankle [155], breast 
tissues [141, 156, 157], articular cartilage in knees [158], and uterine leiomyomas [154]. DEI is 
not highly reliant on imaging energy and therefore, allows samples to be imaged with less 
radiation exposure compared to conventional methods [152, 159]. It was found that the surface 
radiation dose of breast tissue specimens imaged with DEI at 60 keV was substantially lower 
(0.1 mGy) than conventional mammography at 30 keV (25.6 mGy) [157].  
1.3.3.1.2 Propagation-Based Imaging (PBI) 
In PBI, the detector is placed further away from the sample compared to conventional 
radiography (Figure 1. 4A, B). The placement of the detector close to the sample, as in 
conventional radiography, enables the detection of only absorption contrast [160, 161]. 
Increasing the sample-detector distance will allow the transmitted X-rays from the sample to 
propagate further and produce phase distortions due to the interference of refracted and 
unrefracted X-rays [138, 150, 162, 163]. Increasing the gap between sample and detector also 
prevents scatter from reaching the detector whereas conventional radiographic images always 
contain scatter [123, 141]. In propagation based images, strong interference patterns are observed 
when there is a large difference between the refractive indices of two materials. The interference 
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pattern is also known as the ‘edge-enhancement effect’ because it creates dark and bright fringes 
at sample boundaries (i.e., between fluid and soft tissue) and improves the overall image quality 
[126, 138, 163]. The edge-enhancement feature of PBI has been shown to improve the 
identification of breast tumors [139, 140].  
1.3.3.1.3 Talbot Grating Interferometry (TGI) 
The beamline setup for TGI imaging includes two identical crystals known as 
‘gratings’:1) phase grating, and 2) absorption grating (Figure 1.4D) [164, 165]. The phase 
grating (G1) is placed behind the object to allow the interference of diffracted x-rays. The 
absorbing analyzer grating (G2) is placed between the first grating and the detector to transform 
the interference fringes into an intensity signal [166]. Without G2, it would be difficult to resolve 
the closely-spaced interference fringes created by G1 [166]. Both refraction and absorption 
contrast can be measured using the grating-based technique [167]. Grating-based imaging is 
more difficult to implement than the other types of phase contrast imaging, because it requires 
careful alignment of the crystals [126]. Grating-based synchrotron techniques have been used to 
image rat kidney tissues [168] and heart ventricle muscles [166].  
Propagation- and analyzer-based synchrotron imaging methods are more effective for 
detecting large variations in the refractive index of tissue structures [168]. The grating-based 
technique is more powerful for detecting subtle refractions of the X-ray beam caused by small 
variations in refractive index of tissues (i.e., weakly absorbing objectives, such as soft tissues) 
[164]. Phase contrast synchrotron imaging can be further optimized by incorporating computed 
tomography (CT) techniques. During CT, the object is rotated while the X-ray beam transversely 
crosses the object of interest [169]. Three dimensional (3D) visualization and characterization of 
biological tissue samples are possible with synchrotron CT imaging [170]. 
1.3.3.2 Synchrotron Image Resolution and Common Artifacts 
Synchrotron image quality can be quantitatively determined by the signal-to-noise ratio 
(SNR), contrast-to-noise ratio (CNR), and spatial resolution [171]. Noise refers to any unwanted 
information that is detected along with the x-ray signal. The SNR is defined by the ratio of the 
signal to the standard deviation of the noise. The measurement of contrast in relation to noise 
will provide a better calculation of how well structures are differentiated from one another [116]. 
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Factors that influence the SNR and CNR include the X-ray energy, imaging time, sample size 
and thickness, and the efficiency of the detector [122]. Spatial resolution is the smallest distance 
at which two individual features can be resolved [171]. Features of the detector and the distances 
from the source (i.e., source-to-object, source-to-detector) contribute to the spatial resolution of 
the image [122].    
Two artifacts that are commonly observed in synchrotron images are beam hardening and 
ring artifacts. Beam hardening is most common when an X-ray beam with a range of 
wavelengths (i.e., polychromatic beam) is used to image a sample [170]. As the polychromatic 
beam traverses an object, the low-energy X-rays are absorbed faster into the tissues than the 
high-energy X-rays [123, 170]. Therefore, the average energy of the outgoing beam is higher 
than the incident beam. The beam hardening effects cause an artificial darkening in the center 
and brightening in the edges of the images [170]. Ring artifacts are generated from imperfect 
detector elements [172]. These shifts can be produced by scanning conditions, such as 
temperature and beam strength [170].  Filtering and calibrating the X-ray beam before it passes 
through the object are possible solutions to synchrotron image artifacts [170]. 
 
 
 
 
 
 
 
 
 
 
 
 
23 
1.4 References 
1.  Soranus o. E. Soranus' gynecology. O. Temkin, trans. Baltimore: Johns Hopkins 
University Press; 1991:258. 
2.  Hunter R. H. F. Mammalian ovaries, Graafian follicles and oocytes: selected historical 
landmarks. Physiology of the Graafian Follicle and Ovulation. 2003 ed. Cambridge: 
Cambridge University Press; 2003:379. 
3.  Speroff L. F., M. The ovary - Embryology and development. Clinical Gynecologic 
Endocrinology and Infertility. Vol 7ed. Philadelphia: Lippincott Williams & Wilkins; 
2005:97-99. 
4.  Netter F. H. Atlas of human anatomy. Summit: Ciba-Geigy Corporation; 1989. 
5.  Adams G. P. and Pierson R. A. Bovine model for study of ovarian follicular dynamics 
in humans. Theriogenology. 1995; 43(1): 113-120. 
6.  Gougeon A. Dynamics of human follicle growth: Morphologic, fynamic, and functional 
aspects. In: E. Y. A. Peter C.K. Leung, ed. The Ovary. 2 ed. California: Elsevier 
Academic Press; 2004:25-38. 
7.  Junqueira L. C. U. The female reproductive system. In: A. L. Mescher, ed. Junqueira's 
basic histology : text and atlas 12th ed. New York: McGraw-Hill Medical; 2010. 
8.  Strauss J. F. and Williams C. J. The ovarian life cycle. Yen & Jaffe's Reproductive 
Endocrinology (6th Edition). Philadelphia: W.B. Saunders; 2009:155-190. 
9.  Mossman H. W. and Duke K. L. Comparative morphology of the mammalian ovary. 
Madison: The University of Wisconsin Press; 1973:461. 
10.  Reynolds S. R. M. The vascularity of the ovary and ovarian function. Recent Prog. 
Horm. Res. 1950; 565 - 100. 
11.  Peters H. and McNatty K. Morphology of the ovary. The ovary - A correlation of 
structure and function in mammals. Great Britain: Paul Elek Ltd.; 1980:12-18. 
12.  Acosta T. J. and Miyamoto A. Vascular control of ovarian function: ovulation, corpus 
luteum formation and regression. Animal Reproduction Science. 2004; 82-83127-140. 
13.  Basset D. The changes in the vascular pattern of the ovary of the albino rat during the 
oestrous cycle. Am. J. Anat. 1943; 73251 - 291. 
14.  Eli G. and Jaffe R. Ovarian angiogenesis. In: E. Y. A. Peter and C. K. Leung, eds. The 
Ovary. 2 ed. California: Elsevier Academic Press; 2004:305 - 317. 
15.  Mitchell G. A. The innervation of the ovary, uterine tube, testis and epididymis. J Anat. 
1938; 72(Pt 4): 508-517. 
16.  Mohsin S. and Pennefather J. N. The sympathetic innervation of the mammalian ovary. 
A review of pharmacological and histological studies. Clin Exp Pharmacol Physiol. 1979; 
6(3): 335-354. 
17.  Neilson D., Seegar J., Donald W. and Benjamin G. The innervation of the ovary. 
Obstet Gynecol Surv. 1970; 25889 - 904. 
18.  Owman C., Rosenbren E. and Sjoberg N. O. Adrenergic innervation of the human 
female reproductive organs: a histochemical and chemical investigation. Obstet Gynecol. 
1967; 30(6): 763-773. 
19.  Morris B. and Sass M. The formation of lymph in the ovary. Proc. Roy. Soc. B. 1966; 
164577 - 591. 
20.  Kezele P. and Skinner M. Regulation of ovarian primordial follicle assembly and 
development by estrogen and progesterone: endocrine model of follicle assembly. 
Endocrinology. 2003; 144(8): 3329-3337. 
24 
21.  Crisp T. Organization of the ovarian follicle and events in its biology: oogenesis, 
ovulation or atresia. Mutation Research/Reviews in Genetic Toxicology. 1992; 296(1-2): 
89 - 106. 
22.  Gartner L. P., Hiatt, J. L. Color textbook of histology. Third ed. Philadelphia: Elsevier 
Inc. ; 2007:573. 
23.  Kacinskis M. A., Lucci C. M., Luque M. C. and Bao S. N. Morphometric and 
ultrastructural characterization of Bos indicus preantral follicles. Anim Reprod Sci. 2005; 
87(1-2): 45-57. 
24.  Gougeon A. Human ovarian follicular development: From activation of resting follicles 
to preovulatory maturation. Ann Endocrinol (Paris). 2010; 71(3): 132-143. 
25.  Cui D. Atlas of histology: with functional and clinical correlations. First ed. Philadelphia: 
Lippincott Williams & Wilkins; 2011:439. 
26.  McManus J. and Mowry R. Staining mehods - histologic and histochemical. New York: 
Hoeber Medical Division, Harper & Row Publishers; 1965: 8-57 
27.  Ross MH, Pawlina W and TA B. Female reproductive system. Atlas of Descriptive 
Histology. Massachusetts: Sinauer Associates; 2009:304-312. 
28.  Rodgers R. J., Irving-Rodgers H. F. and van Wezel I. L. Extracellular matrix in 
ovarian follicles. Mol Cell Endocrinol. 2000; 163(1–2): 73-79. 
29.  Binelli M. and Murphy B. D. Coordinated regulation of follicle development by germ 
and somatic cells. Reprod Fertil Dev. 2010; 22(1): 1-12. 
30.  McGee E. A. and Hsueh A. J. Initial and cyclic recruitment of ovarian follicles. Endocr 
Rev. 2000; 21(2): 200-214. 
31.  Eppig J. J. Oocyte control of ovarian follicular development and function in mammals. 
Reproduction. 2001; 122(6): 829-838. 
32.  Baerwald A. R., Adams G. P. and Pierson R. A. A new model for ovarian follicular 
development during the human menstrual cycle. Fertil Steril. 2003; 80(1): 116-122. 
33.  Park S., Goldsmith L. and Weiss G. Age-related changes in the regulation of 
luteinizing hormone secretion by estrogen in women. Experimental Biology and 
Medicine. 2002; 227455 - 464. 
34.  Weiss G. and Goldsmith L. Puberty and pediatric and adolescent gynecology. In: J. 
Scott, P. DiSaia, C. Hammond and W. Spellacy, eds. Danforth's Obstetrics and 
Gynecology. 7 ed. Philadelphia: JP Lippincott Co.; 1994:611 - 619. 
35.  Mihm M., Gangooly S. and Muttukrishna S. The normal menstrual cycle in women. 
Anim Reprod Sci. 2011; 124(3-4): 229-236. 
36.  Harlow S., Windham G. and Paramsothy P. Menstruation and menstrual disorders: the 
epidemiology of menstruation and menstrual dysfunction. In: M. Goldman, R. Troisi and 
K. Rexrode, eds. Women and Health. San Diego, CA: Academic Press; 2000:99 - 113. 
37.  Adams G. P., Singh J. and Baerwald A. R. Large animal models for the study of 
ovarian follicular dynamics in women. Theriogenology. 2012; 78(8): 1733-1748. 
38.  Baerwald A. Human antral folliculogenesis: what we have learned from the bovine and 
equine models. Anim. Reprod. 2009; 6(1): 20-29. 
39.  Baerwald A. R., Adams G. P. and Pierson R. A. Ovarian antral folliculogenesis during 
the human menstrual cycle: a review. Hum Reprod Update. 2012; 18(1): 73-91. 
40.  Ginther O. J., Gastal E. L., Gastal M. O., Bergfelt D. R., Baerwald A. R. and 
Pierson R. A. Comparative study of the dynamics of follicular waves in mares and 
women. Biol Reprod. 2004; 71(4): 1195-1201. 
25 
41.  Smith M. Estrus and menstrual cycles: neuroendocrine control. In: L. Squire, ed: 
Academic Press; 2009:1-5. 
42.  O.J. G., Beg M. A., Bergfelt D. R., Donadeu F. X. and Kot K. Follicle selection in 
monovular species. Biol Reprod. 2001; 65638-647. 
43.  Hess A., Nayak N. and Giudice L. Oviduct and endometrium: cyclic changes in the 
primate oviduct and endometrium. In: J. Neill, ed. Physiology of Reproduction. 3 ed. St. 
Louis, MO: Elsevier Academic Press; 2006:337-382. 
44.  Bomsel-Helmreich O. Ultrasound and the preovulatory human follicle. Oxf Rev Reprod 
Biol. 1985; 71-22. 
45.  Baerwald A. R., Adams G. P. and Pierson R. A. Form and function of the corpus 
luteum during the human menstrual cycle. Ultrasound Obstet Gynecol. 2005; 25(5): 498-
507. 
46.  Espey L. and Richards J. Ovulation. In: J. Neill, ed. Knobil and Neill's Physiology of 
Reproduction. Vol 1. St. Louis, MO: Elsevier Academic Press; 2006:425-474. 
47.  Pierson R. A., Martinuk S. D., Chizen D. R. and Simpson C. W. Ultrasonographic 
visualization of human ovulation. In: J. Evers and M. Heineman, eds. From Ovulation to 
Implantation: Proceedings of the 7th Reinier de Graaf Symposium. Amsterdam: Elsevier 
Science Publishers (Biomedical Division); 1990:73-79. 
48.  Croxatto H. B. Female reproductive physiology/function. In: H. Kris, ed. International 
Encyclopedia of Public Health. Oxford: Academic Press; 2008:603-613. 
49.  Pierson R. A. and Chizen D. R. Transvaginal diagnostic ultrasonography in evaluation 
and management of infertility. Journal SOGC. 1991; 37 - 49. 
50.  Devoto L., Fuentes A., Kohen P., Céspedes P., Palomino A., Pommer R., Muñoz A. 
and Strauss Iii J. F. The human corpus luteum: life cycle and function in natural cycles. 
Fertility and Sterility. 2009; 92(3): 1067-1079. 
51.  Eppig J. Oocyte control of ovarian follicular development and function in mammals. 
Reproduction. 2001; 122829 - 838. 
52.  Augustin H. G. Vascular morphogenesis in the ovary. Baillière's Best Practice and 
Research in Clinical Obstetrics and Gynaecology. 2000; 14(6): 867-882. 
53.  Fields MJ and PA F. Morphological characteristics of the bovine corpus luteum during 
the estrous cycle and pregnancy. Theriogenology. 1996; 45(7): 1295-1325. 
54.  Baerwald AR A. G., Pierson RA. Form and function of the corpus luteum during the 
human menstrual cycle. Ultrasound Obstet Gynecol. 2005; 25(5): 498 -507. 
55.  Miyazaki T., Tanaka M., Miyakoshi K., Minegishi K., Kasai K. and Yoshimura Y. 
Power and colour Doppler ultrasonography for the evaluation of the vasculature of the 
human corpus luteum. Hum Reprod. 1998; 13(1O): 2836-2841. 
56.  Backstrom T., Nakata M. and Pierson R. A. Ultrasonography of normal and aberrrant 
luteogenesis. In: R. Jaffe, R. Pierson and J. Abramowicz, eds. Imaging in infertility and 
reproductive endocrinology. Philadelphia: J.B. Lippincott Company; 1994:143-154. 
57.  Gougeon A. Dynamics for human follicular growth: Morphologic, dynamic, and 
functional aspects. In: P. Leung and E. Adashi, eds. The Ovary. 2nd ed. San Diego, 
California: Elseiver Academic Press; 2004:25 - 38. 
58.  Macklon N. S. and Fauser B. C. J. M. Follicle-stimulating hormone and advanced 
follicle development in the human. Archives of Medical Research. 2001; 32(6): 595-600. 
26 
59.  Chang M.D M.-Y., Chiang M.D C.-H., Hsieh M.D T. s.-T. a., Soong M.D Y.-K. and 
Hsu Ph.D K.-H. Use of the antral follicle count to predict the outcome of assisted 
reproductive technologies. Fertility and Sterility. 1998; 69(3): 505-510. 
60.  Rodgers R. J., Irving-Rodgers H. F., van Wezel I. L., Krupa M. and Lavranos T. C. 
Dynamics of the membrana granulosa during expansion of the ovarian follicular antrum. 
Molecular and Cellular Endocrinology. 2001; 171(1–2): 41-48. 
61.  Fauser B. C. Follicle pool depletion: factors involved and implications. Fertil Steril. 
2000; 74(4): 629-630. 
62.  Alonso-Pozos I., Rosales-Torres A. M., Avalos-Rodriguez A., Vergara-Onofre M. 
and Rosado-Garcia A. Mechanism of granulosa cell death during follicular atresia 
depends on follicular size. Theriogenology. 2003; 60(6): 1071-1081. 
63.  Gutierrez C. G., Glazyrin A. L., Robertson G. W., Campbell B. K., Gong J. G., 
Bramley T. A. and Webb R. Ultra-structural characteristics of bovine granulosa cells 
associated with maintenance of oestradiol production in vitro. Mol Cell Endocrinol. 
1997; 134(1): 51-58. 
64.  Krause W. and Cutts J. The female reproduction sSystem. Concise Text of Histology. 
Baltimore: Williams & Wilkins; 1981:367-371. 
65.  Westhoff C., Murphy P. and Heller D. Predictors of ovarian follicle number. Fertil 
Steril. 2000; 74(4): 624-628. 
66.  Ruess M. L., Kline J., Santos R., Levin B. and Timor-Tritsch I. Age and the ovarian 
follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol. 1996; 
174(2): 624-627. 
67.  Baker T. A quantitative and cytological study of germ cells in human ovaries. Proc R 
Soc Biol. 1963; 158417 - 433. 
68.  Hsu A., Arny M., Knee A., Bell C., Cook E., AL N. and DR G. Antral follicle count in 
clinical practice: analyzing clinical relevance. Fertility and Sterility. 2010; 95(2): 474 - 
479. 
69.  Bancsi L., Broekmans F., Eijkemans M., DeJong F., Habbema J. and TeVelde E. 
Predictors of poor ovarian response in in-vitro fertilization: a prospective study 
comparing basal markers of ovarian reserve. Fertil Steril. 2002; 77328 - 336. 
70.  Gibreel A., Maheshwari A., Bhattacharya S. and Johnson N. Ultrasound tests of 
ovarian reserve; a systematic review of accuracy in predicting fertility outcomes. Hum 
Fertil (Camb). 2009; 1295 - 106. 
71.  Ng E., Tang O. and Ho P. The significance of the number of antral follicles prior to 
stimulation in predicting ovarian responses in an IVF programme. Hum Reprod. 2000; 
151937 -1942. 
72.  Vanden Brink H., Chizen D., Hale G. and Baerwald A. R. Age-related changes in 
major ovarian follicular wave dynamics during the human menstrual cycle. Menopause. 
2013. 
73.  Bigelow B. Comparison of ovarian and endometrial morphology spanning the 
menopause. Obstet Gynecol 1958; 11(5): 487 - 513. 
74.  Tatone C. and Amicarelli F. The aging ovary-the poor granulosa cells. Fertil Steril. 
2013; 99(1): 12-17. 
75.  Paszkowski T., Clarke R. and Hornstein M. Smoking induces oxidative stress inside 
the Graafian follicle. Human Reproduction. 2002; 17(4): 921 - 925. 
27 
76.  Malhi P. S., Adams G. P. and Singh J. Bovine model for the study of reproductive 
aging in women: follicular, luteal, and endocrine characteristics. Biol Reprod. 2005; 
73(1): 45-53. 
77.  Singh J., Pierson R. A. and Adams G. P. Ultrasound image attributes of the bovine 
corpus luteum: structural and functional correlates. J Reprod Fertil. 1997; 109(1): 35-44. 
78.  Pierson R. A. and Adams G. P. Computer-assisted image analysis, diagnostic 
ultrasonography and ovulation induction: Strange bedfellows. Theriogenology. 1995; 
43(1): 105-112. 
79.  Forde N., Beltman M. E., Lonergan P., Diskin M., Roche J. F. and Crowe M. A. 
Oestrous cycles in Bos taurus cattle. Anim Reprod Sci. 2011; 124(3–4): 163-169. 
80.  Peter A. T., Levine H., Drost M. and Bergfelt D. R. Compilation of classical and 
contemporary terminology used to describe morphological aspects of ovarian dynamics 
in cattle. Theriogenology. 2009; 71(9): 1343-1357. 
81.  Sartori R. and Barros C. M. Reproductive cycles in Bos indicus cattle. Animal 
Reproduction Science. 2011; 124(3–4): 244-250. 
82.  Senger P. Pathways to pregnancy and parturition. Pullman, WA: Current Conceptions, 
Inc.; 2003. 
83.  Gangestad S. W. and Thornhill R. Human oestrus. Proc Biol Sci. 2008; 275(1638): 
991-1000. 
84.  Hansel W. and Asdell S. The causes of bovine metestrous bleeding. J ANIM SCI. 1952; 
11346-354. 
85.  Block E. Quantitaive morphological investigations of the follicular system in women; 
methods of quantitative determinations. Acta Anatomica. 1951; 12(3): 267 - 285. 
86.  Block E. Quantitaive morphological investigatiosn of the follicular system in women; 
variations int he different phases of the sexual cycle. Acta endocrinol 1951; 333 - 54. 
87.  Crang RFE and KL K. Artefacts in biological electron microscopy. New York: Plenium 
Press; 1988. 
88.  Luna L. G. Manual of histologic staining methods of the armed forces institute of 
pathology. Third ed. New York: McGraw-Hill Book Company; 1968:258. 
89.  Buesa R. Histology without formalin? Annals of Diagnostic Pathology. 2008; 12. 
90.  Burns W. and Bretschneider A. Thin is in: Plastic embedding of tissues for light 
microscopy. Chicago: American Society of Clinical Pathologists; 1981. 
91.  Junqueira L. The female reproductive system. In: A. Mescher, ed. Junqueira's basic 
histology: text and atlas. 12 ed. New York: McGraw-Hill MEdical; 2010:1-15. 
92.  Hillman H. Limitations of clinical and biological histology. Medical Hypotheses. 2000; 
54(4): 553-564. 
93.  Levi S. The history of ultrasound in gynecology 1950-1980. Ultrasound Med Biol. 1997; 
23(4): 481-552. 
94.  McNay M. B. and Fleming J. E. Forty years of obstetric ultrasound 1957-1997: from A-
scope to three dimensions. Ultrasound Med Biol. 1999; 25(1): 3-56. 
95.  Hildebrandt T., Hermes R., Jewgenow K. and Goritz F. Ultrasonography as an 
important tool for the development and application of reproductive technologies in non-
domestic species. Theriogenology. 2000; 5373-84. 
96.  Hearn-Stebbins B., Jaffe R. and Brown H. Ultrasonographic evaluation of normal 
pelvic anatomy. In: R. Jaffe, R. Pierson and J. Abramowicz, eds. Imaging in Infertility 
and Reproductive Endocrinology. Philadelphia: J. B. Lippincott Company; 1994:1-21. 
28 
97.  Medan M. S. and Abd El-Aty A. M. Advances in ultrasonography and its applications 
in domestic ruminants and other farm animals reproduction. Journal of Advanced 
Research. 2010; 1(2): 123-128. 
98.  Pierson R. A., Kastelic J. P. and Ginther O. J. Basic principles and techniques for 
transrectal ultrasonography in cattle and horses. Theriogenology. 1988; 29(1): 3-20. 
99.  Herbener T. E. Ultrasound physics: principles of ultrasonography. Gastrointestinal 
Endoscopy. 1996; 43(2, Part 2): S4-S5. 
100.  Martin K. and Ramnarine K. Physics. In: P. Hoskins, K. Martin and A. Thrush, eds. 
Diagnostic Ultrasound; Physics and Equipment. 2 ed. Cambridge: Cambridge University 
Press; 2010:4-22. 
101.  Case T. D. Ultrasound physics and instrumentation. Surgical Clinics of North America. 
1998; 78(2): 197-217. 
102.  Coltrera M. D. Ultrasound physics in a nutshell. Otolaryngologic Clinics of North 
America. 2010; 43(6): 1149-1159. 
103.  Martin K. B-mode instrumentation. In: P. Hoskins, K. Martin and A. Thrush, eds. 
Diagnostic Ultrasound: Physics and Equipment. Cambridge: Cambridge University 
Press; 2010:47 - 63. 
104.  Martin K. Introduction to B-mode imaging. In: P. Hoskins, K. Martin and A. Thrush, 
eds. Diagnostic Ultrasound: Physics and Equipment. 2nd ed. Cambridge: Cambridge 
University Press; 2010:1-22. 
105.  Srivastava A. K. Basic Ultrasound instrumentation. In: S. K. Bhargava, ed. Principles 
and Practice of Ultrasonography. Pangbourne, UK: Alpha Science International Ltd.; 
2003:27-40. 
106.  Gonzalez-Bulnes A., Pallares P. and Vazquez M. I. Ultrasonographic imaging in small 
ruminant reproduction. Reprod Domest Anim. 2010; 45 Suppl 29-20. 
107.  Speca S., Summaria V. and Marano P. Ultrasonography in gynecology: normal 
anatomy. European Journal of Ultrasound. 1996; 477-89. 
108.  Bushberg J., Seibert J., Leidholdt E. and Boone J. Ultrasound. In: J.-R. John, A. 
Snyder and T. DeGeorge, eds. The essential physics of medical imaging. 2 ed. 
Philadelphia, PA: Lippincott Williams & Wilkins; 2002:469-498. 
109.  Ng A. and Swanevelder J. Resolution in ultrasound imaging. Contin Educ Anaesth Crit 
Care Pain. 2011; 11(5): 186-192. 
110.  Martin K. Properties, limitations and artefacts of B-mode images. In: P. Hoskins, K. 
Martin and A. Thrush, eds. Diagnostic Ultrasound: Physics and Equipment. Cambridge: 
Cambridge University Press; 2010:64-74. 
111.  Edmondson A. J., Fissore R. A., Pashen R. L. and Bondurant R. H. The use of 
ultrasonography for the study of the bovine reproductive tract. I. Normal and pathological 
ovarian structures. Anim Reprod Sci. 1986; 12(3): 157-165. 
112.  Duck F. and Shaw A. Safety of diagnostic ultraound. In: P. Hoskins, K. Martin and A. 
Thrush, eds. Diagnostic Ultrasound: Physics and Equipment. 2 ed. Cambridge: 
Cambridge University Press; 2010:155-170. 
113.  Suortti P. and Thomlinson W. Medical applications of synchrotron radiation. Phys Med 
Biol. 2003; 48(13): R1-35. 
114.  Elliott A. Medical Imaging. Nucl Instrum Meth A. 2005; 5461-13. 
115.  Hoheisel M. Review of medical imaging with emphasis on X-ray detectors. Nucl Instrum 
Meth A. 2006; 563215-224. 
29 
116.  Suetens P. Radiology. Fundamentals of medical imaging. Cambridge, UK: Cambridge 
University Press; 2002:47-64. 
117.  Westneat M. W., Socha J. J. and Lee W. K. Advances in biological structure, function, 
and physiology using synchrotron X-ray imaging*. Annu Rev Physiol. 2008; 70119-142. 
118.  Elder F., Gurewitsch A., Langmuir R. and Pollock H. Radiation from electrons in a 
synchrotron. Physical Review. 1947; 71(829): 3, 7, 8. 
119.  Garcia-Gutierrez M. and Rueda D. Bases of synchrotron radiation, light sources, and 
features of X-ray scattering beamlines. In: M. Gomez, A. Nogales, M. Garcia-Gutierrez 
and T. Ezquerra, eds. Applications of synchrotron light to scattering and diffraction in 
materials and life sciences. Vol 776. Online: Lecture Notes in Physics; 2009:1-22. 
120.  Margaritondo G. Elements of Synchrotron Light for Biology, Chemistry and Medical 
Research. Oxford: Oxford University Press; 2002:1-255. 
121. Bharath A. Introductory Medical Imaging. Vol 27. San Rafael, California: Morgon and 
Claypool Publishers; 2009:3-37. 
122.  Smith N. and Webb A. X-ray planar radiology and computed tomography. Introduction 
to medical imaging: Physics, engineering and clinical applications. Cambridge, UK: 
Cambridge University Press; 2011:34-83. 
123.  Guy C. and ffytche D. An introduction to the principles of medical imaging. Revised ed. 
Covent Garden, London: Imperial College Press; 2005:1-374. 
124.  Kitchen M. J., Lewis R. A., Yagi N., Uesugi K., Paganin D., Hooper S. B., Adams G., 
Jureczek S., Singh J., Christensen C. R., Hufton A. P., Hall C. J., Cheung K. C. and 
Pavlov K. M. Phase contrast X-ray imaging of mice and rabbit lungs: a comparative 
study. The British Journal of Radiology. 2005; 781018-1027. 
125.  Lewis R. Medical phase contrast x-ray imaging: current status and future prospects. 
Physics in Medicine and Biology. 2004; 493573 - 3583. 
126.  Margaritondo G. Applications of synchrotron light Elements of synchrotron light for 
Biology, Chemistry, & Meidcal Research. Oxford: Oxford University Press; 2002. 
127.  Kocsis M. and Snigirev A. Imaging using synchrotron radiation. Nucl Instrum Meth A. 
2004; 525(1–2): 79-84. 
128.  Socha J. J., Westneat M. W., Harrison J. F., Waters J. S. and Lee W.-K. Real-time 
phase-contrast x-ray imaging: a new technique for the study of animal form and function. 
BMC Biology. 2007; 5(6). 
129.  Baruchel J., Bleuet P., Bravin A., Coan P., Lima E., Madsen A., Ludwig W., Pernot 
P. and Susini J. Advances in synchrotron hard X-ray based imaging. Comptes Rendus 
Physique. 2008; 9(5–6): 624-641. 
130.  Monfraix S., Bayat S., Porra L., Berruyer G., Nemoz C., Thomlinson W., Suortti P. 
and Sovijarvi R. Quantitative measurement of regional lung gas volume by synchrotron 
radiation computed tomography. Physics in Medicine and Biology. 2004; 501-11. 
131.  Porra L., Monfraix S., Berruyer G., Le Duc G., Nemoz C., Thomlinson W., Suortti 
P., Sovijarvi A. R. and Bayat S. Effect of tidal volume on distribution of ventilation 
assessed by synchrotron radiation CT in rabbit. J Appl Physiol. 2004; 96(5): 1899-1908. 
132.  Greenlee K. J., Henry J. R., Kirkton S. D., Westneat M. W., Fezzaa K., Lee W.-K. 
and Harrison J. F. Synchrotron imaging of the grasshopper tracheal system: 
morphological and physiological components of tracheal hypermetry. Am J. Physiol 
Regul Integr Comp Physiol. 2009; 297R1343 - R1350. 
30 
133.  Umetani K., Uesugi K., Kobatake M., Yamamoto A., Yamashita T. and Imai S. 
Synchrotron radiation microimaging in rabbit models of cancer for preclinical testing. 
Nucl Instrum Meth A. 2009; 609(1): 38-49. 
134.  Chien C. C., Wang C. H., Wang C. L., Li E. R., Lee K. H., Hwu Y., Lin C. Y., 
Chang S. J., Yang C. S., Petibois C. and Margaritondo G. Synchrotron 
microangiography studies of angiogenesis in mice with microemulsions and gold 
nanoparticles. Anal Bioanal Chem. 2010; 397(6): 2109-2116. 
135.  Tanaka E., Tanaka A., Sekka T., Shinozaki Y., Hyodo K., Umetani K. and Mori H. 
Digitized cerebral synchrotron radiation angiography: quantitative evaluation of the 
canine circle of Willis and its large and small branches. Am J Neuroradiol. 1999; 20(5): 
801-806. 
136.  Schültke E., Fiedler S., Nemoz C., Ogieglo L., Kelly M. E., Crawford P., Esteve F., 
Brochard T., Renier M., Requardt H., Le Duc G., Juurlink B. and Meguro K. 
Synchrotron-based intra-venous K-edge digital subtraction angiography in a pig model: A 
feasibility study. European Journal of Radiology. 2010; 73(3): 677-681. 
137.  Ohtsuka S., Hyodo K., Jin W., Takeda T., Maruhashi A., Yamaguchi I. and Ando 
M. Overview of clinical intravenous coronary angiography both in Japan and at ESRF. 
Nucl Instrum Meth A. 2005; 548(1-2): 78-83. 
138.  Arfelli F., Bonvicini V., Bravin A., Cantatore G., Castelli E., Palma L., Michiel M., 
Fabrizioli M., Longo R., Menk R., Olivo A., Pani S., Pontoni D., Poropat P., Prest 
M., Rashevsky A., Ratti M., Rigon L., Tromba G., Vacchi A., Vallazza E. and 
Zanconati F. Mammography with synchrotron radiaiton: Phase-detection techniques. 
Radiology. 2000; 215286 - 293. 
139.  Ingal V., Beliaevskaya E., Brianskaya A. and Merkurieva R. Phase mammography - a 
new technique for breast investigation. Phys. Med. Biol. 1998; 432555 - 2567. 
140.  Keyrilainen J., Bravin A., Fernandez M., Tenhunen M., Virkkunen P. and Suortti 
P. Phase-contrast X-ray imaging of breast. Acta Radiol. 2010; 51(8): 866-884. 
141.  Pisano E., Johnston R., Chapman D., Geradts J., Iacocca M., Livasy C., Washburn 
D., Sayers D., Zhong Z., Kiss M. and Thomlinson W. Human breast cancer specimens: 
Diffraction enhacned imaging with histologic correlation - improved conspicuity of 
lesion detail compared with digital radiography. Radiology. 2000; 214895 - 901. 
142.  Yoon C. Y., Sung D. J., Lee J. H., Kim A. R., Oh C. W., Je J. H., Weon B. M., Seol 
S. K., Pyun A., Hwu Y., Margaritondo G., Joo K. J. and Yoon D. K. Imaging of renal 
and prostate carcinoma with refractive index radiology. Int J Urol. 2007; 14(2): 96-103. 
143.  Blattmann H., Gebbers J. O., Bräuer-Krisch E., Bravin A., Le Duc G., Burkard W., 
Di Michiel M., Djonov V., Slatkin D. N., Stepanek J. and Laissue J. A. Applications 
of synchrotron X-rays to radiotherapy. Nucl Instrum Meth A. 2005; 548(1–2): 17-22. 
144.  Christensen C., Singh J., Adams G., Choo-Smith L.-P. and Jackson M. Infrared and 
Raman spectroscopic imaging of bovine corpora lutea. Microsc Microanal. 2004; 
10(Suppl 2): 1324-1325. 
145.  Kuehnel S., Reinhard S., Schmidt J., Herzen J., Beckmann F., Kleinteich T. and 
Kupfer A. Evolutionary reproductive biology of amphibians: Novel insights using 
synchrotron based highresolution X-ray computed microtomography. Photon Science-
HASYLAB Annual report. DESY Photon Science2009:1-2. 
31 
146.  Bergmann P., Laumann M., Cloetens P. and Heethoff M. Morphology of the internal 
reproductive organs of Archegozetes longisetosus Aoki (Acari, Oribatida). Soil 
Organisms. 2008; 80(2): 171-195. 
147.  Wood B. R., Chernenko T., Matthaus C., Diem M., Chong C., Bernhard U., Jene C., 
Brandli A. A., McNaughton D., Tobin M. J., Trounson A. and Lacham-Kaplan O. 
Shedding new light on the molecular architecture of oocytes using a combination of 
synchrotron Fourier transform-infrared and Raman spectroscopic mapping. Anal Chem. 
2008; 80(23): 9065-9072. 
148.  Kim A. M., Bernhardt M. L., Kong B. Y., Ahn R. W., Vogt S., Woodruff T. K. and 
O'Halloran T. V. Zinc sparks are triggered by fertilization and facilitate cell cycle 
resumption in mammalian eggs. ACS Chem Biol. 2011; 6(7): 716-723. 
149.  Han L., Monné M., Okumura H., Schwend T., Cherry A. L., Flot D., Matsuda T. 
and Jovine L. Insights into egg coat assembly and egg-sperm interaction from the X-ray 
structure of full-length ZP3. Cell. 2010; 143(3): 404-415. 
150.  Zhou S. A. and Brahme A. Development of phase-contrast X-ray imaging techniques 
and potential medical applications. Phys Med. 2008; 24(3): 129-148. 
151.  Chapman D., Pisano E., Thomlinson W., Zhong Z., Johnston R. E., Washburn D., 
Sayers D. and Malinowska K. Medical applications of diffraction enhanced imaging. 
Breast Disease. 1998; 10(3-4): 197-207. 
152.  Chapman D., Thomlinson W., Johnston R. E., Washburn D., Pisano E., Gmur N., 
Zhong Z., Menk R., Arfelli F. and Sayers D. Diffraction enhanced x-ray imaging. Phys 
Med Biol. 1997; 42(11): 2015-2025. 
153.  Pagot E., Fiedler S., Cloetens P., Bravin A., Coan P., Fezzaa K., Baruchel J., 
Hartwig J., Von Smitten K., Leidenius M., Karjalainen-Lindsberg M. and 
Keyrilainen J. Quantitative comparison between two phase contrast techniques: 
diffraction enhanced imaging and phase propagation imaging. Phys Med Biol. 2005; 
50(4): 709 - 724. 
154.  Liu C., Zhang Y., Zhang X., Yang W., Peng W., Shi D., Zhu P., Tian Y. and Huang 
W. X-ray diffraction-enhanced imaging of uterine leiomyomas. Med Sci Monitor. 2005; 
11(5): MT33-38. 
155.  Li J., Zhong Z., Lidtke R., Kuettner K. E., Peterfy C., Aliyeva E. and Muehleman C. 
Radiography of soft tissue of the foot and ankle with diffraction enhanced imaging. J 
Anat. 2003; 202(5): 463-470. 
156.  Bravin A., Keyrilainen J., Fernandez M., Fiedler S., Nemoz C., Karjalainen-
Lindsberg M. L., Tenhunen M., Virkkunen P., Leidenius M., von Smitten K., Sipila 
P. and Suortti P. High-resolution CT by diffraction-enhanced x-ray imaging: mapping 
of breast tissue samples and comparison with their histo-pathology. Phys Med Biol. 2007; 
52(8): 2197-2211. 
157.  Faulconer L., Parham C., Connor D., Zhong Z., Kim E., Zeng D., Livasy C., Cole E. 
B., Kuzmiak C., Koomen M., Pavic D. and Pisano E. Radiologist evaluation of an x-
ray tube-based diffraction-enhanced imaging prototype using full-thickness breast 
specimens Acad Radiol. 2009; 161329-1337. 
158.  Mollenhauer J., Aurich M. E., Zhong Z., Muehleman C., Cole A. A., Hasnah M., 
Oltulu O., Kuettner K. E., Margulis A. and Chapman L. D. Diffraction-enhanced X-
ray imaging of articular cartilage. Osteoarth Cartilage. 2002; 10(3): 163-171. 
32 
159.  Parham C., Zhong Z., Connor D. M., Chapman L. D. and Pisano E. D. Design and 
implementation of a compact low-dose diffraction enhanced medical imaging system. 
Acad Radiol. 2009; 16(8): 911-917. 
160.  Arfelli F., Assante M., Bonvicini V., Bravin A., Cantatore G., Castelli E., Dalla 
Palma L., Di Michiel M., Longo R., Olivo A., Pani S., Pontoni D., Poropat P., Prest 
M., Rashevsky A., Tromba G., Vacchi A., Vallazza E. and Zanconati F. Low-dose 
phase contrast x-ray medical imaging. Phys Med Biol. 1998; 43(10): 2845-2852. 
161.  Olivo A., Rigon L., Vinnicombe S. J., Cheung K. C., Ibison M. and Speller R. D. 
Phase contrast imaging of breast tumours with synchrotron radiation. Applied Radiation 
and Isotopes. 2009; 67(6): 1033-1041. 
162.  Fitzgerald R. Phase-sensitive X-ray imaging. Physics Today. 2000; 53(7): 23-26. 
163.  Snigirev A., Snigireva I., Kohn V., Kuznetsov S. and Schelokov I. On the possibilities 
of x-ray phase contrast microimaging by coherent high-energy synchrotron radiation. 
Rev. Sci. Instrum. 1995; 66(12): 5486 - 5492. 
164.  Momose A., Washiro W., Takeda Y., Suzuki Y. and Hattori T. Phase-imaging with an 
x-ray talbot interferometer. JCPDS-International Centre for Diffraction Data. 2006; 21-
30. 
165.  Pinzer B. R., Cacquevel M., Modregger P., McDonald S. A., Bensadoun J. C., 
Thuering T., Aebischer P. and Stampanoni M. Imaging brain amyloid deposition 
using grating-based differential phase contrast tomography. Neuroimage. 2012; 61(4): 
1336-1346. 
166.  Weitkamp T., David C., Bunk O., Bruder J., Cloetens P. and Pfeiffer F. X-ray phase 
radiography and tomography of soft tissue using grating interferometry. Eur J Radiol. 
2008; 68(3, Supplement): S13-S17. 
167.  Donath T., Pfeiffer F., Bunk O., Grunzweig C., Hempel E., Popescu S., Vock P. and 
David C. Toward clinical X-ray phase-contrast CT: demonstration of enhanced soft-
tissue contrast in human specimen. Invest Radiol. 2010; 45(7): 445-452. 
168.  Momose A. Phase-sensitive imaging and phase tomography using X-ray interferometers. 
Optics Express. 2003; 11(9): 2303 - 2314. 
169.  Arfelli F. Synchrotron light and imaging stystems for medical radiology. Nucl Instrum 
Meth A. 2000; 45411-25. 
170.  Ketcham R. and Carlson W. Acquisition, optimization and interpretation of X-ray 
computed tomographic imagery: applications to the geosciences. Computers & 
Geosciences. 2001; 27381-400. 
171.  Smith N. and Webb A. General image characteristics, data acquisition and image 
reconstruction. Introduction to medical imaging: Physics, engineering and clinical 
applications. Cambridge, UK: Cambridge University Press; 2011:1-30. 
172.  Sijbers J. and Postnov A. Reduction of ring artefacts in high resolution micro-CT 
reconstructions. Phys Med Biol. 2004; 49(14): N247-253.  
 
33 
 
Chapter 2 
GENERAL OBJECTIVES AND HYPOTHESIS 
 
 The overall objective of the work presented was to determine if synchrotron-based 
biomedical imaging techniques would be effective for imaging ovaries compared to conventional 
ultrasonography and histology. The specific objectives were to: 1) explore Diffraction Enhanced 
Imaging (DEI) as a technique for evaluating bovine ovaries (Chapter 3), and 2) evaluate 
Propagation-Based CT (PB-CT) and Talbot Grating Interferometry-CT (TGI-CT) techniques for 
evaluating both bovine and human ovaries (Chapter 4).  
 The general hypothesis was that DEI, PB-CT and TGI-CT synchrotron techniques would 
provide improved image contrast for evaluating ovarian structures (i.e., follicles ≥2mm, small 
antral follicles <2mm, corpora lutea, cumulus oocyte complexes, and cell layers of the follicle 
wall) compared to conventional ultrasonography and histology. 
 
The following specific hypotheses were examined. 
Study 1 (Chapter 3 - Diffraction Enhanced Synchrotron Imaging of Bovine Ovaries Ex Vivo):  
 Follicle and luteal diameter measurements would be more accurately assessed 
with DEI versus ultrasonography, using histology as a reference 
 The number of follicles ≥2mm detected with DEI would be greater than that of 
ultrasonography. 
 DEI would enable the detection of smaller antral follicles compared to 
ultrasonography.  
 DEI would enable the detection of cumulus oocyte complexes and small antral 
follicles <2mm, whereas ultrasonography would not. 
 
 
 
 
 
34 
 
Study 2 (Chapter 4 - Synchrotron Imaging of Bovine and Human Ovaries Ex Vivo: Propagation-
based Phase Contrast and Talbot Grating Interferometry Techniques): 
 Follicle and luteal diameter measurements would be more accurately assessed 
with PB-CT versus ultrasonography, using histology as a reference. 
 Follicle wall measurements would be more accurately assessed using PB-CT 
versus ultrasonography.  
 PB-CT would enable the detection of smaller follicles compared to 
ultrasonography. 
 PB-CT and TGI-CT would enable the detection of cumulus oocyte complexes and 
small antral follicles <2mm, whereas ultrasonography does not.  
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3.0 Preface 
The following study (Chapter 3) was conducted to qualitatively and quantitatively 
compare Diffraction Enhanced Imaging (DEI) and conventional ultrasonography for imaging 
bovine ovaries. In a preliminary study, Christensen et al. showed that DEI offers promise for 
imaging bovine ovaries. The study described in this chapter is an extension of the earlier study to 
compare both DEI and diagnostic ultrasonography to the gold standard, histology. DEI has been 
documented to be an effective synchrotron technique for imaging soft tissues, such as breast and 
lung tissue. The aim of our study was to determine whether DEI synchrotron methods are 
effective for imaging bovine and human ovaries. 
This manuscript will be submitted for publication in the Journal of Medical Imaging and 
Radiation Sciences (JMIRS). The contributions of the primary author (Upekha Basnayaka) to 
this manuscript include the following: 10% study design, 70% data collection, 65% data 
analyses/interpretation, 45% manuscript preparation and 80% presentation of study findings. The 
co-authors are acknowledged for contributing to study design, data collection and developing the 
manuscript.  
Research described in the following paper was performed at the Canadian Light Source 
(CLS, Saskatoon, SK) which is supported by the Natural Sciences and Engineering Research 
Council of Canada, the National Research Council Canada, the Canadian Institutes of Health 
Research (CIHR), the Province of Saskatchewan, Western Economic Diversification Canada, 
and the University of Saskatchewan. The authors would like to acknowledge Dr. Jaswant Singh 
and Darren Nesbitt (Veterinary Biomedical Sciences, Western College of Veterinary Medicine, 
University of Saskatchewan) for their assistance in conducting histological analysis in the 
present study. Appreciation is also expressed to Adam Webb at the CLS for his expertise in 
acquiring and analyzing synchrotron data. Funding for this study was provided by a CIHR- 
Training Grant in Health Research Using Synchrotron Techniques as well as new faculty start-up 
funds from the College of Medicine at the University of Saskatchewan. 
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3.1 Abstract 
Objectives: The objective of this study was to test the hypothesis that Diffraction Enhanced 
Imaging (DEI), a synchrotron X-ray imaging technique, would provide greater contrast for 
evaluating bovine ovaries compared to conventional diagnostic ultrasonography. 
Materials and Methods: Bovine ovaries were evaluated ex vivo: fresh without radiographic 
arterial contrast (n=2), fresh with contrast (n=1), preserved in 10% formalin without contrast 
(n=2), and preserved with contrast (n=1). Each ovary was imaged with DEI and subsequently 
with US and histology. The ability to visualize and differentiate pre-antral and antral follicles, 
corpora lutea (CL) and cumulus oocyte-complexes (COC) were compared using DEI, US and 
histology. The diameter of follicles and CL were measured and compared using ultrasonography, 
DEI, and histology. The diameter of the smallest follicle detected was reported using each of the 
three imaging methods. The number of antral follicles (Antral Follicle Count; AFC; ≥2mm) was 
compared between US and DEI.  
Results: DEI enabled the detection of 71% of follicles and 67% of CL that were detected using 
ultrasonography. However, DEI did not allow the detection of COC and cell layers of the follicle 
wall that were visualized with histology. Luteal tissues were not easily distinguished using DEI; 
DEI was inferior for differentiating follicles and CL compared to US. Mean follicle diameter was 
similar between DEI (9.6 ± 2.4 mm), ultrasonography (9.0 ± 2.6 mm), and histology (6.9 ± 1.9 
mm) in fresh ovaries with no contrast (P = 0.7). However, mean follicle diameter in fresh ovaries 
without contrast was greater using both DEI (4.0 ± 0.4 mm) and ultrasonography (3.9 ± 0.3 mm) 
compared to histology (2.2 ± 0.4 mm), (P=0.01). Mean CL diameter was similar between DEI 
(11.6 ± 1.7 mm), ultrasonography (9.3 ± 0.4 mm), and histology (9.6 ± 0.4 mm), (P = 0.34). The 
mean diameter of the smallest follicle detected was similar between DEI (3.1±0.4 mm) and 
ultrasonography (3.0 ± 0.7 mm), albeit both DEI and ultrasonography measurements were 
greater than histology (0.4 ± 0.04 mm), (P<0.0001). Mean AFC was similar between 
ultrasonography (6.5 ± 0.7 mm, fresh with no contrast; 6.5 ± 2.5 mm, preserved with no contrast) 
and DEI ( 4.5 ±  0.5 mm, fresh with no contrast; 6.5 ±  0.5 mm, preserved with no contrast), (P > 
0.05). Preservation of tissues and the injection of contrast into the ovarian arteries did not alter 
the quality of images obtained with DEI. 
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Discussion: The contrast resolution of antral follicles, CL and COC in bovine ovaries using DEI 
was inferior to ultrasonography and histology. Additional synchrotron techniques, such as Phase-
Contrast Computed Tomography (CT) or DEI-CT, may prove more effective for imaging ovaries 
ex vivo.  
Keywords: Bovine – Ovary – Synchrotron – Ultrasonography – Diffraction Enhanced Imaging 
 
3. 2 Introduction 
The evaluation of morphologic and functional properties of human tissues is essential for 
understanding physiology and pathophysiology. The most commonly used method for examining 
reproductive tissues in women is conventional ultrasonography [1]. Ultrasonographic imaging is 
considered to be rapid, clinically safe and portable [1-4]. An ultrasonographic image consists of 
2-dimensional pixels or 3-dimensional voxels with varying degrees of brightness. The brightness 
of each pixel or voxel corresponds to the amplitude of the echoes created as high frequency 
sound waves are reflected from tissue interfaces [5,6]. Human ovaries can be imaged either 
transvaginally or transabdominally [2,4]. Greater resolution for imaging the ovaries is achieved 
using a transvaginal versus a transabdominal probe [4]. Ultrasonography has enabled the 
assessment of ovarian structure and function (i.e., follicle and luteal development, ovulation), as 
well as detection of pathological abnormalities of the ovary (i.e., polycystic ovaries, ovarian 
tumors) [4,6-12]. 
Despite providing a direct and non-invasive method for examining the ovaries, 
ultrasonography is limited in its ability to provide high-resolution images of ovarian 
microanatomy. Conventional transvaginal ultrasonography enables the detection and 
measurement of structures ≥2 mm in diameter in the ovaries [13,14]. Thus, pre- and early- antral 
(i.e., fluid-filled) ovarian follicles, as well as the female germ cells (i.e., oocytes), are not 
visualized [15-17]. Ultrasonographic imaging in patients with a large body mass is often 
challenging because a lower frequency is required to penetrate deeper in to the target organs 
resulting in a lesser resolution of structures [18]. In addition, the presence of bowel gas can 
impede the transmission of ultrasound beams and create artifacts when imaging the ovaries. 
Thus, limitations of conventional ultrasonography provide rationale for the development of novel 
high resolution tools to image ovaries for both clinical and research purposes. 
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The synchrotron, a high energy particle accelerator, is a novel tool for imaging soft 
tissues. The synchrotron provides a wide X-ray energy spectrum with a high photon flux that 
allows the selection of a monochromatic photon beam with a narrow wavelength band [19-24]. 
The selection of a specific energy allows samples to be imaged with less radiation exposure or 
dose compared to conventional X-ray imaging [20,25]. Synchrotron radiation can be applied to 
studies in various fields including material science, crystallography, micro-spectroscopy, and 
biomedical imaging [19].  
 Diffraction Enhanced Imaging (DEI) is a type of phase-sensitive or refraction-based 
synchrotron imaging which can be used for imaging soft tissues. DEI involves the use of a 
crystal, known as an analyzer, which is placed between the sample and detector [26]. The setup 
for DEI imaging is shown in Figure 3.1. The analyzer can be placed in various positions on a 
rocking curve to obtain data from which images can be obtained of refraction, absorption, and 
scatter rejection [26,27].  The relative energy intensity of DEI is a function of the angular 
position of the crystal. X-rays that are aligned with the analyzer are detected [28]. Apparent 
absorption images are created by mapping contrast arising from the absorption and scattering of 
X-rays. X-ray scatter arises from small structures within the sample [29,30]. The majority of 
scatter from the sample is eliminated by the small angular acceptance of the crystal analyzer. 
Placing the analyzer at the top of the rocking curve yields an image that is nearly free from 
scatter. Therefore, DEI images from the top contain contrast from absorption and rejection of 
small and ultra-small X-ray scattering [29]. In conventional X-ray radiography, the separation of 
scatter from absorption contrast is not possible [30]. Refraction DEI images contain only 
refracted contrast information which arises from density variations in the sample [26]. In planar 
or 2D DEI, the structures within the entire sample are superimposed in a single image. DEI 
allows the investigator to detect minute changes in the projected refractive index of a sample, 
such as boundaries or edges which are often undetected with conventional radiography [26].  
Another advantage of DEI is that it is not highly dependent on imaging energy allowing samples 
to be imaged with a lower radiation dose [26,31].  
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Figure 3.1 Synchrotron beamline setup for Diffraction Enhanced Imaging (Chapman, et al., 
2013, unpublished) 
 
 
DEI has been used in humans to image bone and soft tissues of the foot and ankle [32], 
normal and pathological breast tissue [30,33,34], articular cartilage in knee joints [35] and 
uterine leiomyomas [29]. DEI has been further used to examine lung damage and liver tissue 
morphology in rats [36,37]. A preliminary study was conducted in 2002 to examine DEI of a 
single excised bovine ovary [38]. Results obtained from this early research indicated that bovine 
ovarian follicles >4 mm and corpora lutea (CL) could be detected using DEI at 40 keV [38]. This 
proof-of-principle study, however, did not include comparisons with conventional imaging 
methods or histology. Animal species are often used for initial imaging studies because of ethical 
restrictions associated with using human tissues. The bovine species has been well established as 
a model for studying reproductive functions in women [7,39]. Further investigations are required 
to determine the effectiveness of synchrotron DEI for evaluating bovine ovarian anatomy and 
physiology. Research of this nature may assist in optimizing medical imaging tools for the 
research and clinical evaluation of human ovaries. 
  The objective was to determine the effectiveness of DEI for evaluating bovine ovaries ex 
vivo. We hypothesized that DEI would provide greater contrast resolution for detecting and 
differentiating ovarian structures including antral follicles <2 mm, cell layers of the follicle wall, 
cumulus oocyte complexes (COC), and CL compared to conventional diagnostic 
ultrasonography.   
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3. 3 Materials and Methods 
3.3.1 Study Samples 
 A prospective, observational pilot study was conducted from 2011 – 2013. Fresh bovine 
ovaries (n= 6) were obtained from local abattoirs. The ovarian artery of each specimen was 
flushed with saline immediately after collection, and the ovaries were transported in normal 
saline at room temperature to the Canadian Light Source (CLS) synchrotron facility at the 
University of Saskatchewan. The CLS operates at an energy of 2.9 GeV and a current of 250 mA 
[40]. The ovaries were imaged in the following conditions: fresh without contrast (n=2), fresh 
with an ovarian artery injection of 4 mL of iodine-based contrast agent (Ioversol, Optiray 240) 
(n=1), preserved in 10% formalin with no contrast (n=2), or preserved with contrast (n=1). The 
gross morphology of each ovary was imaged using a digital camera (Samsung NV24HD, Korea). 
Ethical approval for conducting this study was obtained from the Animal Research Ethics Board 
at the University of Saskatchewan. 
 
3.3.2 Imaging Techniques 
 
 Ovarian samples were imaged with planar DEI at the BioMedical Imaging and Therapy 
(BMIT) beamline at the CLS using an energy of 40 keV and pixel size of 20 µm. Ovaries were 
placed in a saline-filled, rectangular, plastic container (6 cm x 3.5 cm x 2 cm) with a piece of 
rubber tubing on the bottom for stabilization (Figure 3.2). Visible air bubbles inside the container 
were manually removed using a pipette before imaging. A silicon crystal with a 2, 2, 0 lattice 
configuration was used. Images were obtained at the top, 0.5 (+/-), and 0.25 (+/-) positions on the 
rocking curve using a CCD array detector and camera (Photonic Science Ltd, Robertsbridge, 
East Sussex, UK).   
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Figure 3.2 Sample setup for imaging a bovine ovary by Diffraction Enhanced Imaging at the 
Canadian Light Source synchrotron  
 
Following synchrotron imaging, ovarian samples were imaged using a portable 
diagnostic ultrasonographic system equipped with a 6.6 MHz convex-array probe (MyLab Five, 
Esaote, Indianapolis, Indiana, USA). Ovaries were placed in degassed saline and imaged 
ultrasonographically along the long axis of the ovary. Imaging was conducted at a penetration 
depth of 6 cm using an overall gain of 52% for all ovaries, with no magnification. One focal zone 
was placed at a depth of 2.5 cm. 
Ovarian samples were placed in 10% Formalin immediately following synchrotron and 
ultrasonographic imaging. Ovaries were serially sectioned at 5 µm thickness using a microtome. 
Every 4th section was selected for hematoxylin and eosin staining. Images of the histological 
slides were obtained using a digital camera with a 50mm focal length (Nikon D90, Nikon Inc., 
Melville, NY, USA).  
 
3.3.3 Qualitative Analyses 
Synchrotron images were reconstructed using ImageJ (Version 1.46, National Institutes 
of Health, Bethesda, MA, USA). DEI image reconstruction included images from the peak and 
both sides of the rocking curve. Apparent absorption and refraction images were also obtained by 
applying an algorithm on a pixel-by-pixel basis, as described by Chapman et al [26]. Interactive 
Data Language (ITT Exelis., Boulder, Colorado, USA) was used to remove artifacts seen as dark 
horizontal bands from the DEI images. Ultrasonographic images were evaluated using Sante 
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DICOM Editor (Version 3.1.23, Athens, Greece). Histologic images were edited using 
ViewNXTM (Version 2.3.0, Nikon Inc., Melville, NY, USA). Ovarian follicles were classified as 
either normal or atretic, based on histologic characteristics. Healthy follicles were characterized 
by the presence of a homogenous and continuous lumen-granulosa and granulosa-theca interface, 
as well as a tightly compacted COC [41]. Follicular atresia was characterized by the presence of 
nuclear condensation in the granulosa cell layer, hypertrophy of theca interna cells, presence of 
cytoplasmic droplets, hyalinized zona pellucida, and separation of cumulus cells [41-43]. 
Qualitative investigations using the three imaging techniques (DEI, ultrasonography and 
histology) included the ability to detect and differentiate ovarian structures (i.e., follicles, CL and 
COC), the quality of images obtained and the presence of artifacts or noise.   
 
3.3.4 Quantitative Analyses 
Structures of interest in corresponding DEI, ultrasonographic and histologic images were 
measured using ImageJ (Version 1.46, National Institutes of Health, Bethesda, MA, USA). For 
each follicle ≥2 mm or CL detected, diameter was calculated as the mean of the longest and 
widest perpendicular measurements (i.e., length and width) along the long axis of the ovary. 
Diameter measurements were made using a magnification of 1.5X for DEI images, 2.5X for 
ultrasonographic images, and 1.5X for histology images. The smallest follicle detected with all 
three imaging techniques was also reported [16]. Antral Follicle Count (AFC, defined as the 
number of follicles ≥2 mm detected) was tabulated for each ovary using both ultrasonography 
(1.33X magnification) and DEI (1.33X magnification). All images were scaled according to their 
pixel dimensions using ImageJ (Version 1.46, National Institutes of Health, Bethesda, MA, 
USA). 
  The primary study outcome measure was the ability to detect follicle, CL, or COC within 
the ovaries. Secondary outcomes measures included follicle diameter, luteal diameter and AFC. 
Study endpoints were compared among DEI, ultrasonography and histology techniques using 
One-Way Analysis of Variance (ANOVA) with Tukey’s post hoc tests when significance 
(P<0.05) was detected. Statistical analyses were conducted using SPSS (Version 20.0, Chicago, 
IL, USA).  
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3.4 Results 
3.4.1 Qualitative Findings 
 DEI images of scatter rejection (top of the rocking curve), apparent absorption and 
refraction (both from the sides of the rocking curve) were obtained for each ovary (Figure 3.3a-
c). Antral follicles of varying diameters were characterized as circular structures with less 
(Figure 3.3a) or similar (Figure 3.3c) contrast compared to the surrounding tissue. All follicles 
detected within the ovary were superimposed within a single DEI image (Figure 3.3c). The 
refraction image (Figure 3.3c) was more effective for discriminating the borders of antral 
follicles and CL compared to the scatter rejection (Figure 3.3a) and absorption (Figure 3.3b) 
images. The amount of contrast in the apparent absorption images was insufficient to visualize 
follicles or CL (Figure 3.3b). Artifacts, visualized as dark horizontal bands across the images 
(Figure 3.3b, c), were initially observed using DEI.  Artifacts were attributed to the image 
reconstruction process and were removed prior to quantitative analyses.  
 
 
 
 
 
 
 
 
Figure 3. 3 Diffraction enhanced images of a fresh bovine ovary with contrast. Images of the top 
of the rocking curve (a; scatter-free), apparent absorption (b), and refraction (c) are shown 
 
Images of gross morphology (a, b), ultrasonography (c, d), DEI (e, f), and histology (g, h) 
of two fresh (i.e., unpreserved) ovaries are shown in Figure 3.4. In the ultrasonographic images, 
antral follicles appeared as dark, anechoic, circular structures with a poorly-defined border 
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(Figures 3.4c, d). In DEI images, follicles appeared as circular structures with a well-defined 
border and homogeneous echotexture within the antral cavity (Figures 3.4e, f). Antral cavity 
heterogeneity was observed when multiple follicles were superimposed on each other (Figure 3. 
4f). About 37/52 (71%) of follicles ≥2 mm detected with ultrasonography were detected with 
DEI. COC were not detected in either ultrasonogrpahy or DEI images. COC, however, were 
detected as circular protrusions into the follicular antrum in some of the histological sections. 
Individual cell layers of the follicle wall (i.e., granulosa and theca) were detected with histology, 
but not DEI or ultrasonography. Ovarian blood vessels that were visualized within the ovarian 
medulla with histology were not detected in the DEI or grey-scale ultrasonographic images.  
Six out of nine (67%) of CL identified with ultrasonography were retrospectively 
identified using DEI. In Figure 3.4c, the CL was visualized ultrasonographically as a circular 
structure containing a heterogeneous central cavity, representing a hemorrhagic cyst. The blood-
filled central cystic cavity was visualized ultrasonographically to be hyperechoic compared to 
antral follicles. The CL was identified in the DEI images as a well-circumscribed circular 
structure with or without a central fluid-filled cavity. In Figure 3.4e, the contrast of the CL in the 
DEI images was similar to neighboring follicles in many cases; thus, it was difficult to 
differentiate CL from follicles using DEI.  
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Figure 3.4 Gross morphology (a, b), ultrasonographic (c, d), DEI (e, f; at +0.5 position on the 
rocking curve), and histologic (g, h) images of two separate fresh bovine ovaries. Ovarian 
samples imaged with (a, c, e, g) and without (b, d, f, h) contrast are shown. Examples of ovarian 
follicles (orange θ), corpora lutea (yellow *), and air bubbles (red arrow) are indicated. Dashed 
lines on the gross images indicate the plane of sectioning.  
47 
 
Air bubbles were visualized in some DEI images as bright white (high contrast), circular 
structures <1.0 mm surrounded by a black halo (Figures 3.4e). Several small high contrast 
circular structures denser than air bubbles (measuring approximately 0.25 mm) were identified in 
one sample (Figure 3.4f). We postulated that these structures represented microcalcifications of 
the ovary. However, the identity of these structures was not confirmed in the corresponding 
histologic images.  
The quality of the DEI images was not influenced by the injection of contrast (Figure 3.4 
e, f) or preservation (Figure 3.5 a, b) 
 
 
Figure 3.5 Diffraction enhanced images of a fresh (a) and formalin-fixed (b) bovine ovary. 
Images were taken at the +0.5 position of the rocking curve. Examples of ovarian follicles 
(orange θ), corpora lutea (yellow *) and air bubbles (red arrow) are shown. Other follicles not 
indicated in the image are also present.  
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3.4.2 Quantitative Findings 
Corresponding ovarian structures (i.e., follicles, CL) visualized with all three imaging 
techniques (n=3) were evaluated quantitatively. The DEI image attributes of normal versus 
atretic were not different (P>0.05); therefore, data for normal and atretic follicles were 
combined. However, the use of radiographic contrast appeared to confound the effect of imaging 
techniques on ovarian measurements. Therefore, data are reported separately for ovaries 
evaluated with versus without contrast.  
Follicle ≥2 mm and CL diameter measurements made from DEI, ultrasonographic and 
histologic images are compared in Table 3.1. Mean follicle diameter in fresh ovaries with 
contrast was similar between DEI and ultrasonography; however, follicle diameter was greater 
for both DEI and ultrasonography compared to histology (P = 0.01). Mean follicle diameter in 
fresh ovaries without contrast was similar among the 3 techniques (P>0.05). Mean CL diameter 
in fresh ovaries without contrast were similar between DEI, ultrasonography, and histology 
(P>0.05). 
Table 3.1 Ovarian follicle and corpus luteum (CL) diameter (Mean ± Standard Error) assessed 
by histology, ultrasonography, and Diffraction Enhanced Imaging (DEI) of 3 fresh excised 
bovine ovaries (n=number of follicles or corpora lutea)  
Sample Condition n  Histology 
(mm) 
Ultrasonography 
(mm) 
DEI 
(mm) 
P-value 
Follicle Diameter 
Fresh – with  contrast 4 2.2 ± 0.4a 3.9 ± 0.3b 4.0 ± 0.4b 0.01 
Fresh – no  contrast 4 6.9 ± 1.9a 9.0 ± 2.6a 9.6 ± 2.4a 0.70 
CL Diameter 
Fresh – no contrast 2 9.6 ± 0.4a 9.3 ± 0.4a 11.6 ± 1.7a 0.34 
a, b Within rows, values with different superscripts are different (P < 0.05) 
 
Mean AFC measurements were compared between DEI and ultrasonography (Table 3.2). 
There were no differences in mean AFC between DEI and ultrasonography for fresh or preserved 
samples (without contrast P>0.05) 
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Table 3.2 Mean Antral Follicle Count (AFC; Mean ± Standard Error) in excised bovine ovaries 
assessed by ultrasonography versus Diffraction Enhanced Imaging (DEI) 
Ovarian Sample Number of 
ovaries 
Ultrasonography DEI P-value 
Fresh – with contrast   
Fresh – no  contrast  
Preserved – with contrast 
Preserved – no contrast 
1 
2 
1 
2 
17 
6.5± 0.7 
10 
6.5 ± 2.5 
7 
4.5 ± 0.5 
8 
6.5 ± 0.5 
- 
0.11 
- 
1.00 
 
The imaging sensitivity (defined as the smallest follicle detected) of DEI was similar to 
that of ultrasonography, (P=0.225) but the sensitivity of both DEI and ultrasonography was 
inferior to that of histology (3.1 ± 0.4mm, 3.0 ± 0.7mm, 0.4 ± 0.04 mm, respectively; P<0.0001). 
 
3. 5 Discussion 
In this pilot study, we investigated the effectiveness of DEI synchrotron techniques for 
evaluating bovine ovaries ex vivo. Overall, we concluded that DEI (at 40 keV imaging energy, 20 
µm resolution) was not an effective method for imaging the macro and/or microanatomic 
features of bovine ovaries in comparison to conventional 2D ultrasonography and histology. 
Thus, our hypothesis was not supported.  
DEI was capable of detecting antral ovarian follicles >2 mm as well as CL. However, 
only 2/3 of follicles and CL imaged ultrasonographically were detected with DEI. The 
superimposition of follicles in DEI images made identifying individual follicles and CL difficult. 
It was more challenging to identify individual follicles from ovaries with a larger AFC with DEI 
versus ultrasonography. Furthermore, we were not able to differentiate antral follicles from CL 
in DEI images because the contrast of the luteal tissue was similar to that of the follicles. We 
attributed the inferior contrast resolution of the DEI images to the small variation between the 
projected refractive indices of the luteal tissues and follicles [26]. Other microscopic details of 
the ovary observed histologically (including COC, vasculature, cell layers of the follicle wall, 
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and small follicles <2 mm) were not visualized with either DEI or ultrasonography. Although the 
ability to consistently detect antral follicles and CL was limited, DEI was as accurate as 
ultrasonography for measuring follicular and luteal diameter. Both DEI and ultrasonography, 
however, were inferior to histology for measuring the diameter of follicles and CL in ovaries 
with contrast. Overall, we concluded that DEI was inferior to ultrasonography for imaging antral 
follicles and CL. 
AFC has been shown to be one of the best predictors of ovarian reserve (i.e., the number 
of pre-antral and antral follicles within the ovaries) in women. As a result, AFC can be used to 
predict the timing of onset of menopause as well the ovarian response to human assisted 
reproductive therapies [39,44,45]. Current methods for measuring AFC are limited to detecting 
follicles ≥2 mm in diameter. In addition, there is a great degree of intra and interobserver 
variability in measuring AFC, in particular for follicles < 2 mm.  In the present study, AFC for 
follicles ≥ 2mm was similar using DEI and conventional 2D ultrasonography. However, DEI did 
not allow the detection and quantification of antral follicles less than 2 mm in diameter. 
Therefore, we concluded that DEI does not provide an additional advantage over 
ultrasonography for determining AFC. 
One of the biggest limitations of our study was the sample size. In general, it takes about 
30 – 60 minutes to obtain five images on the DEI rocking curve. Each ovary took approximately 
2-3 hours to image due to beam instability issues, thereby limiting the number of samples we 
could image within a given period of time. The evaluation of 6 ovarian samples was a suitable 
starting point for making qualitative assessments in this pilot project. However, the small sample 
size likely led to error in the quantitative endpoints (i.e., follicle diameter, luteal diameter, AFC) 
compared among the 3 imaging methods. In addition, it was difficult to determine the precise 
locations of structures within the ovary when comparing different imaging techniques. Follicles 
and CL identified with DEI were carefully marked with indelible ink, as a reference point for 
subsequent ultrasonographic imaging and histologic sectioning. Despite this strategy, small 
variations in the position of follicles and CL during DEI, ultrasonography and histology imaging 
may have contributed to error in our study. 
 DEI is only one phase-sensitive synchrotron imaging technique. Other phase-sensitive 
techniques for imaging soft tissues include in-line Phase-Contrast Computed Tomography (CT), 
Talbot grating interferometry, and DEI-CT [28,46,47]. Future research should be conducted to 
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examine the use of DEI-CT methods for imaging bovine and/or human ovaries. DEI-CT should 
not result in the overlapping of internal structures associated with planar DEI, and may thereby 
improve the ability to delineate individual follicles [34,48]. Furthermore, optimization of 
synchrotron modalities for imaging ovaries may assist in understanding female reproductive 
pathophysiology (i.e., infertility, ovarian malignancies) and provide a working model for 
imaging other soft tissues (i.e., prostate, breast). 
In summary, Diffraction Enhanced synchrotron techniques used in the present study were 
inferior for imaging bovine ovaries ex vivo compared to conventional 2D ultrasonography. DEI 
was not an effective tool for detecting antral follicles, CL, or COC within the ovaries. Future 
research should focus on alternative configurations of DEI and/or different synchrotron imaging 
techniques for imaging bovine and human ovaries, such as DEI-CT or Phase-Contrast CT. The 
development of novel high-resolution synchrotron techniques for imaging bovine and human 
ovaries may provide valuable insight into ovarian physiology such as pre-antral and early antral 
follicular dynamics as well as follicle-oocyte-interactions.  
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4.0 Preface  
The following study (Chapter 4) was conducted to investigate two phase-contrast based 
synchrotron techniques, Propagation-based Computed Tomography (PB-CT) and Talbot Grating 
Interferometry (TGI-CT), for imaging bovine and human ovaries. Synchrotron-based PB-CT and 
TGI-CT of bovine and human ovaries have not been previously investigated.  
This manuscript will be submitted for publication in Academic Radiology. The 
contributions of the primary author (Upekha Basnayaka) to this manuscript include the 
following: 10% study design, 50% data collection, 65% data analyses/interpretation, 45% 
manuscript preparation and 80% presentation of study findings. The co-authors are 
acknowledged for contributing to study design, data collection and revising the manuscript.  
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4.1 Abstract 
Objective: To test the hypothesis that Propagation-Based Computed Tomography (PB-CT) and 
Talbot Grating Interferometry Computed Tomography (TGI-CT) synchrotron techniques would 
provide greater contrast for imaging ovarian anatomy compared to conventional 2D 
ultrasonography.  
Materials and Methods: A prospective, observational study was conducted at the Canadian 
Light Source to qualitatively and quantitatively compare ovarian imaging using PB-CT, 
ultrasonography, and histology. Bovine ovaries were imaged as follows: fresh without contrast 
(n=1); fresh with iodine-based contrast (n=2); and formalin-fixed with contrast (n=1). Human 
ovaries were imaged without contrast as fresh (n=2) and preserved (n=2) samples. The feasibility 
of TGI-CT to image preserved bovine (n=1) and human (n=1) ovaries was further evaluated at 
SPring-8, Japan.   
Results: 100% of antral follicles ≥2mm and 100% of corpora lutea (CL) detected with 
ultrasonography were identified with PB-CT. Mean follicle and luteal diameter did not differ 
between PB-CT, ultrasonography and histology (P>0.05). The smallest follicle detected was 
superior with PB-CT (0.9±0.4mm) compared to ultrasonography (2.2±0.2 mm, P<0.05). PB-CT, 
but not ultrasonography, allowed the detection of the cell layers comprising the follicle wall 
(P<0.05). TGI-CT provided greater contrast for evaluating follicles, CL and vasculature 
compared to PB-CT and ultrasonography. High contrast spherical structures resembling cumulus 
oocyte complexes (COC) were detected with both PB-CT and TGI-CT, but not ultrasonography. 
Discussions: PB-CT was as effective as ultrasonography for measuring follicle and luteal 
diameter. However, PB-CT was superior to ultrasonography for visualizing ovarian 
microanatomy, including follicles <2mm, cell layers of the follicle wall, and COC. TG-CT 
appears to provide the greatest resolution for imaging ovarian anatomy compared to both 
ultrasonography and PB-CT.  
Keywords:  
Ovary – Human – Bovine – Synchrotron – Propagation-based Imaging – Grating Interferometry  
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4.2 Introduction 
Non-invasive imaging technologies are essential for understanding the structural and 
functional properties of biological tissues. Currently, the most commonly used method for 
evaluating human reproductive tissues is ultrasonography because it is non-invasive, safe, and 
portable [1-3]. Ultrasonographic images are comprised of 2D pixels or 3D voxels. Each pixel or 
voxel displays a varying degree of brightness that corresponds to the amplitude of the echo 
created as a sound wave is reflected from within a tissue[4, 5]. Obstetrical and gynecologic 
applications of ultrasonography include, but are not limited to, monitoring ovarian and uterine 
function during the menstrual cycle (i.e., follicular, luteal, and endometrial development; 
ovulation), assessment of embryonic, fetal, and placental development, as well as the diagnosis 
and treatment of  infertility and pregnancy disorders [5-12]. 
Ultrasonography has profoundly improved our ability to monitor reproductive function 
and early development in vivo. However, the detection of ovarian structures <2 mm in size, such 
as early developing follicles, cell layers of the follicle wall, and oocytes is not currently possible 
using conventional 2-dimensional ultrasonography [13, 14]. In addition, the resolution of 
ultrasonographic imaging is restricted by penetration depth [6, 15], as well as artifacts caused by 
intestinal activity and gas [6, 15, 16]. The development of novel high-resolution imaging 
technologies may provide a means to increase our understanding of the biologic mechanisms 
underlying human ovarian function (i.e., follicle development, oogenesis, ovulation and 
luteogenesis) and female reproductive pathophysiology. 
Synchrotron radiation has been used to image normal and pathological states of 
biological tissues. Synchrotron imaging involves the acceleration of electrons to create a high-
energy light beam. Synchrotron imaging can be conducted with a lower radiation exposure 
compared to conventional X-ray methods due to the selection of a photon beam with a narrow 
energy range [17-23]. 
Phase contrast synchrotron imaging utilizes both the refraction and absorption properties 
of objects to provide images of greater contrast resolution compared to conventional X-ray 
imaging [24, 25]. As the synchrotron beam traverses an object, the X-rays are refracted and 
absorbed.  The amount of refraction and absorption depends upon the properties of objects, such 
as thickness and density [24-27]. Contrast, produced the differences in tissue properties, is 
detected and projected onto the image. Phase contrast imaging is about 1000 times more 
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powerful for detecting subtle density changes in soft tissues compared to conventional 
radiography [17, 27-32].  
There are three different synchrotron applications that utilize phase-contrast techniques: 
1) Diffraction Enhanced Imaging (DEI), 2) Propagation-based imaging (PBI), and 3) Talbot 
Grating Interferometry (TGI).  With each technique, the sample is placed in-line with the 
incoming X-ray beam. The X-rays that pass through the sample are captured by a detector which 
converts the X-rays into visible light [30]. The phase contrast techniques above can be combined 
with Computed Tomography (CT) by rotating the sample and obtaining 2D slices for each 
projection [33, 34].  
In DEI, a crystal (known as an analyzer) is placed between the sample and the detector 
[35]. The incident X-ray beam passes through the sample and refracts onto the analyzer crystal 
[27]. Only the X-rays that are selectively accepted by the crystal will be diffracted onto the 
detector [36]. Information regarding the refraction, absorption and scatter rejection of X-rays 
from a sample can be obtained with DEI [36, 37]. DEI provides high sensitivity for visualizing 
microcalcifications and subtle distortions in human breast tissue compared to conventional 
mammography. DEI has been shown to enable the detection of bovine ovarian follicles and 
corpora lutea (CL) [38] , albeit at a lesser resolution than conventional ultrasonography [35].  
With PBI, the distance between the sample and detector is increased so that the 
transmitted X-rays travel further and produce phase distortions [27, 39]. The phase distortions 
create strong interference patterns between refracted X-rays of the sample and unrefracted X-
rays of the background [26, 31]. The interference patterns produce an ‘edge-enhancement effect’ 
at sample boundaries, which improves the overall image quality [26, 31, 40]. PBI techniques 
have been used to examine mouse and rabbit lungs [25] as well as the human kidney and prostate 
[41]. TGI imaging uses two crystals to measure the refraction-induced lateral displacement 
caused by wave interference [39, 42]. The first crystal (i.e., phase grating) is placed behind the 
sample to create X-ray interference and the second crystal (i.e., absorption grating) is placed 
between the first crystal and the detector to transform the interference fringes into an intensity 
signal [43]. TGI imaging is useful for weakly-absorbing soft tissues. However, it is more 
difficult to implement than other phase-contrast techniques [18]. TGI studies have previously 
been conducted using the mouse heart [43], knee joint[44], and brain [44, 45]. However, no data 
have been published on the use of either PB-CT or TGI imaging for imaging ovaries.  
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The objective of this study was to determine the effectiveness of PB-CT and TGI-CT for 
imaging bovine and human ovaries. We hypothesized that PB-CT and TGI-CT would provide 
greater contrast resolution for imaging ovarian structures (i.e., antral follicles, cumulus oocyte 
complexes (COC), CL) compared to conventional 2D ultrasonography.   
 
4.3 Materials and Methods 
A prospective, observational pilot study was conducted from 2011 – 2013. Ethical 
approval for conducting this study was obtained from the Animal Care Committee and the 
Biomedical Research Ethics Board at the University of Saskatchewan as well as the Strategic 
Health Information and Planning Services Unit of the Saskatoon Health Region. Research 
procedures were conducted in accordance with the Tri-Council Policy Statement on the Ethical 
Conduct for Research Involving Humans, and the Canadian Council on Animal Care. All human 
participants provided informed consent before initiating study procedures.  
4.3.1 Imaging Techniques 
A. Propagation-Based CT Imaging  
(i) Sample Collection, Set Up and Design 
Phase 1: Fresh bovine ovaries (n=4) were obtained from local abattoirs. The ovarian artery was 
flushed with saline within 30 minutes of removal. Samples were imaged in the following 
conditions: 
1. fresh without contrast (n=1); 
2. fresh with injection of 5-8mL of iodine-based contrast agent (Ioversol, 
OptirayTM240) into the ovary artery (n=2); and, 
3. preserved in 10% Formalin with ovarian artery contrast, as described above (n=1). 
Phase 2: Formalin-fixed human ovarian tissue sections (n=2) were obtained from the Department 
of Pathology at Royal University Hospital. 
Phase 3: Unfixed fresh ovaries (n=2) were obtained in the operating room from women 
undergoing laparoscopic bilateral oophorectomies at the Saskatoon City Hospital (mean age = 
50.5 years; range= 49-52 years). Indications for oophorectomy were as prophylaxis against 
breast and ovarian cancer. 
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For phases 1-3, ovaries were transported in saline at room temperature to the CLS for 
imaging.  PB-CT imaging was conducted on all samples at the BioMedical Imaging and Therapy 
(05B1-1) beamline (BMIT) at the CLS. Ovaries were placed in a plastic cylindrical container and 
filled with fresh room temperature saline in preparation for synchrotron imaging. Air bubbles 
were manually removed from the container prior to imaging. A detector (Hamamatsu, 
manufacturer, location) with a charge-coupled device camera (Model, C9300-124, Manufacturer, 
location) was placed 125 cm from the sample. The source was located at a distance of 27m from 
the sample. A total of 1800 projections with a pixel resolution of 18.8 µm were taken per slice. 
The imaging time for a 5 mm-slice of the ovary took approximately 1.5 hours.  
(ii) Image Reconstruction 
Tomographic PB-CT images were reconstructed using SyrmepTomoProject (Version 2.0, 
Elettra Synchrotron Facility, Trieste, Italy). File conversions and editing of images were 
conducted using ImageJ 1.6.0_20 (National Institutes of Health, USA), HCImage (Version 
2.0.1.2, Hamamatsu Corporation) and Avizo Standard (Edition 7.0.1, Visualization Sciences 
Group). Ring artifacts observed in images were removed using a customized software program 
[46-50]. 
 
B. Talbot Grating Interferometry-CT Imaging  
(i) Sample Collection, Set Up and Design 
TGI-CT imaging was conducted at the SPring-8 synchrotron facility (BL20B2 beamline) in 
Japan. A preserved bovine ovary (n=1) and a preserved human ovarian tissue section (n=1) were 
imaged.  All ovarian samples were embedded in agarose gel and imaged with an X-ray energy of 
25 keV and a pixel resolution of 13.3 µm. Images were obtained with an AA60 (P43 t20um, 
f=105mm lens) detector with an ORCA_Flash4.0 (f=50mm lens) camera. The total scanning 
times for the samples were approximately 2.3 hours (whole ovary) and 1.2 hours (tissue section). 
The CT scan was conducted using 900 projections over 180°. A total of 5 images were obtained 
by shifting the absorption grating.  Specific ovarian regions of interest identified during PB-CT 
were marked with indelible ink. 
(ii) Image Reconstruction 
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Final reconstruction of the TGI-CT images was conducted using a customized software 
program (Kentaro Uesugi & Masato Hoshino, SPring-8, Japan). 
C. Ultrasonographic Imaging  
Following synchrotron imaging, all ovaries imaged with PB-CT and TGI-CT were further 
imaged with 2D ultrasonography using a portable ultrasonographic system (8 MHz curvilinear 
probe; MyLabTMFive, Esaote). Ovaries were imaged in the transverse plane in a saline bath with 
the following configurations: depth of 6 cm; overall gain of 52%; and, a single focal zone at a 
depth of 3 cm. Ultrasonography images were evaluated using Sante DICOM Editor (Version 
3.1.23, Athens, Greece) and ImageJ 1.6.0_20 (National Institutes of Health, USA). All fresh and 
human bovine samples were placed in 10% Formalin following synchrotron and 
ultrasonographic imaging.  
 
D.  Histologic Imaging  
Upon completion of the synchrotron and ultrasonographic imaging, ovaries were 
histologically sectioned and imaged. The specific areas of interest in the ovary marked with 
indelible ink were cut in 3mm slices and histologically processed into paraffin blocks. The 
blocks were then serially sectioned at 5µm thickness using a microtome and every 4th section 
was selected for hematoxylin and eosin staining. Digital images of the histological slides were 
obtained using a digital camera (Nikon D90). Histology images were edited using ViewNXTM 
(Version 2.3.0). Bovine ovaries were histologically imaged at Veterinary Biomedical Sciences, 
Western College of Veterinary Medicine, University of Saskatchewan. Histological gross 
sectioning of the human tissues was conducted in the Departments of Pathology at Royal 
University Hospital and Saskatoon City Hospital. Microsectioning and staining of the human 
ovarian samples for histological evaluation was conducted after standard clinical pathological 
evaluations.  
4.3.2 Qualitative Evaluations: 
 Qualitative evaluations were made for all samples imaged sequentially with PB-CT, TGI-
CT, ultrasonography and histology. The ability to detect ovarian structures of interest (i.e., 
follicles, CL, COC) using each of the 3 imaging techniques was tabulated and compared. 
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Ovarian follicles imaged with histology were labeled as either normal or atretic, based on 
histologic evaluation [51-53].  
4.3.3 Quantitative Evaluations: 
 Quantitative analyses were conducted for PB-CT and corresponding ultrasonography and 
histologic images. The mean diameter of all antral follicles ≥ 2mm and all CL was calculated as 
the average of the length and width obtained using the widest follicular/luteal dimension in the 
transverse plane. The thickness of the follicle wall was measured in replicates at the 2, 4, 8 and 
10 o’clock positions and then averaged. The smallest follicle detected was reported for each of 
the three imaging techniques [54]. The orientation and magnification of images was standardized 
for each technique. All images were scaled according to their pixel dimensions using ImageJ 
(Version 1.46, National Institutes of Health, Bethesda, MA, USA). Ultrasound images were 
magnified 3X for follicle and CL diameter measurements, and 4X for measuring follicle wall 
thickness. Images obtained with PB-CT were magnified 1.75X for follicle and CL diameter and 
2.5X for follicle wall thickness. Histologic images were magnified 2.5X for follicle diameter and 
wall thickness, and 1.25X for CL diameter. Mean follicle diameter, mean luteal diameter, and the 
smallest antral follicle detected were compared among PB-CT, ultrasonography, and histology 
using One-Way ANOVA with Tukey’s post hoc tests (SPSS Version 20.0, Chicago, IL, USA).  
 
4.4 Results 
4.4.1 Propagation-Based Computed Tomography  
Qualitative Assessments: 
Correspondent images of gross morphology, ultrasonography, PB-CT and histology of 
ovarian samples are shown in Fig. 4.1 (a-h). A fresh bovine ovary with contrast (Fig. 4.1 a, c, e, 
g) and a Formalin-fixed human ovarian tissue section without contrast (Fig. 4.1b, d, f, h) are 
shown. Ring-artifacts were observed as dark and bright concentric circles in the reconstructed 
PB-CT images (Fig. 4.1 e, f). The injection of contrast enabled the visualization of ovarian 
vasculature in one bovine ovary, as shown in Figure 4.2 (a, b).  
In Fig. 4.1 (c, d), antral follicles were identified ultrasonographically as dark, anechoic, 
circular structures with a poorly-defined follicular wall. By comparison, antral follicles in the 
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PB-CT images were visualized as low contrast circular structures with a more clearly-visualized 
wall (Fig. 4.1 e, f). All antral follicles ≥ 2mm detected with ultrasonography were detected with 
PB-CT. The granulosa and theca cell layers comprising the follicular wall were detected 100% of 
the time (both bovine and human samples) with PB-CT, but only 88% (bovine) and 78% 
(human) of the time using ultrasonography, when compared to histology (Fig. 4.1 c, e, g).  
The developing CL was visualized ultrasonographically as an irregularly-circumscribed 
structure of mixed echotexture with (Fig. 4.1 d) or without (not shown) a hypo-echogenic blood-
filled cavity. Regressing CL, known as corpora albicantia (CA) exhibited greater 
ultrasonographic echogenicity compared to the surrounding stroma (Fig.4.1 d). CL detected with 
ultrasonography were also visualized with PB-CT in 100% of cases. In the PB-CT image, the 
central cystic cavity of CL exhibited greater contrast resolution compared to the luteal wall (Fig. 
4.1 f).  Therefore, cystic CL was better detected in the PB-CT and histologic images (Fig. 4.1 f, 
h) compared to ultrasonography (Fig. 4.1a, d). Connective tissues of the CA and CL in the PB-
CT images exhibited lower contrast compared to nearby follicles (Fig. 4.1 f). 
Preservation of the ovaries caused slight shrinkage of the tissues. However, no noticeable 
differences in image quality were observed between the fresh and preserved ovaries.  
Quantitative Assessments:  
No differences were observed in mean follicle diameter and follicle wall measurements 
between normal versus atretic follicles (P>0.05). Therefore, quantitative data were combined for 
normal and atretic follicles. Mean follicle diameter, CL diameter, and follicle wall thickness 
were calculated separately for fresh and preserved ovaries. 
Mean follicle and luteal diameter measurements in bovine and human ovaries were not 
different among the PB-CT, ultrasonography and histologic images (Table 4.1, P>0.05). PB-CT 
was more sensitive for detecting small antral follicles in bovine, but not human ovaries, 
compared to ultrasonography (Table 4.2, P = 0.04). One of the bovine ovaries was excluded from 
the calculation of smallest follicle due to inadequate number of histological slices. Mean follicle 
wall thickness in bovine and human ovaries using both PB-CT and histology was smaller 
compared to ultrasonography (Table 4.3, P<0.0001).  
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Figure 4.1 Correspondent images of a fresh bovine ovary with contrast (a, c, e, g) and a 
Formalin-fixed human ovarian tissue segment without contrast (b, d, f, h). Gross morphology (a, 
b), ultrasonography (c, d), PB-CT at 18.8 µm resolution (e, f), and histological (g, h) images are 
displayed. Examples of follicles (orange θ), corpora lutea (yellow *), and corpora albicantia 
(green θ) are indicated. A dashed line on the gross image (a) indicates the plane of sectioning. 
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Figure 4.2 Images of a fresh bovine ovary with contrast obtained with PB-CT at 18.8 µm 
resolution. A 3D reconstructed image of a bovine ovary section (a) and its maximum intensity 
projection image with the outline of the ovarian vasculature (b) are shown.   
 
Table 4.1 Diameter (Mean ± Standard Error) of follicles and corpora lutea in bovine and human 
ovaries (n = number of follicles or corpora lutea) 
Sample Condition n 
 
PB-CT 
 (mm) 
Ultrasonography  
(mm) 
Histology 
(mm) 
P-value 
Bovine Ovaries: Follicle Diameter 
Preserved- with 
contrast 
11 4.2 ± 0.8 4.7 ± 0.8 3.8 ± 0.7 0.72 
Fresh - with contrast 19 4.7 ± 0.7 5.3 ± 0.6 4.0 ± 0.6 0.33 
Fresh  -  no contrast 1 4.6 5.6 5.0 - 
Human Ovaries: Follicle Diameter 
Preserved- no 
contrast 
5 4.6 ± 0.5 4.0 ± 0.43 3.7 ± 0.4 0.38 
Fresh -  no contrast 4 6.1 ± 2.5 5.0 ± 1.8 4.6 ± 1.6 0.79 
Human Ovaries: Luteal Diameter 
Preserved - no 
contrast 
2 8.9 ± 5.4 8.1 ± 3.8 7.0 ± 3.9 0.65 
Fresh -  no contrast 2 3.4 ± 0.5 4.5 ± 0.3 3.6 ± 0.3 0.16 
Mean bovine luteal diameter was not calculated, due to an insufficient number of CL detected in 
the bovine ovaries. 
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Table 4.2 Diameter (Mean ± Standard Error) of the smallest follicle detected in bovine and 
human ovaries 
Sample Condition n  PB-CT 
(mm) 
Ultrasonography 
(mm) 
Histology 
(mm) 
P-value 
Bovine ovaries 3 0.9 ± 0.4a 2.2 ± 0.2b 0.2± 0.1a 0.04 
Human ovaries 4 1.2 ± 0.7a 2.7 ± 0.4a 0.9± 0.6a 0.11 
a, b Within sample types, values with different superscripts are different (P <0.05) 
n= number of ovaries 
 
Table 4.3 Follicle wall thickness (Mean ± Standard Error) in bovine and human ovaries 
 
Sample Condition n  PB-CT 
(mm) 
Ultrasonography 
(mm) 
Histology 
(mm) 
P-value 
Bovine Ovaries 
Preserved- with contrast 10 0.15 ± 0.01a 0.31 ± 0.01b 0.15 ± 0.01a <0.0001 
Fresh - with contrast 17 0.16 ± 0.01a 0.27 ± 0.01b 0.14 ± 0.01a <0.0001 
Fresh  - no contrast 1 0.31 0.14 0.14 - 
Human Ovaries 
Preserved- no contrast 5 0.16 ± 0.01a 0.28 ± 0.02b 0.10 ± 0.01a <0.0001 
Fresh -  no contrast 2 0.17 ± 0.02a 0.30 ± 0.03ab 0.12 ± 0.01a 0.10 
a, b Within sample types, values with different superscripts are different (P < 0.05) 
n = number of follicles 
 
4.4.2 Talbot Grating Interferometry Computed Tomography 
Qualitative Assessments: 
Gross morphology, ultrasonography, PB-CT, and TGI-CT images of a bovine (Fig.4.3 a, 
c, e, g) and human ovarian tissue segment (Fig.4.3 b, d, f, h) were compared. The follicle antrum 
and the theca and granulosa cell layers comprising the follicle wall were visualized with PB-CT 
(Fig. 4.3 e) and TGI-CT (Fig.4.3 g) but not ultrasonography (Fig. 4.3 c). Irregular and 
invaginated walls of the CL were better distinguished with TGI-CT (Fig. 4.3 g, h),compared to 
PB-CT (Fig. 4.3 e, f) and ultrasonography (Fig. 4.3 c, d). Furthermore, ovarian vasculature was 
detected with PB-CT (Fig. 4.3 e, f) and TGI-CT (Fig, 4.3 g, h), but not ultrasonography (Fig, 4.3 
c, d). 
 
68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Correspondent images of a preserved bovine ovary (a, c, e, g) and a Formalin-fixed 
human ovarian tissue segment (b, d, f, h). Gross (a, b), ultrasonographic (c, d), PB-CT at 18.8 
µm resolution (e, f), and TGI-CT at 13.3 µm resolution (g, h) images are shown. Ovarian (orange 
θ), corpora lutea (yellow *), and vasculature (red ∆) are indicated. A dashed line on the gross 
image (a) indicates the plane of sectioning. 
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High contrast spherical structures <0.60 mm, protruding into the antrum from the follicle 
wall were identified bovine ovaries using PB-CT (9 follicles, 3 ovaries) and TGI-CT (7 follicles, 
1 ovary) imaging. These location, size, and shape of these protrusions are consistent with COC; 
however, these structures were not observed in the limited number of histologic sections 
obtained. An example of one COC identified using both PB-CT and TGI-CT imaging is shown 
in Fig. 4.4 (a, b).  
 
 
 
 
 
 
 
 
Figure 4.4 PB-CT (a) and TGI-CT (b) images of the same bovine ovary without contrast. Red 
arrows indicate cumulus-oocyte-complexes, the oocyte surrounded by cumulus cells. 
 
4.5 Discussion 
In this pilot study, we examined the effectiveness of PB-CT and TGI-CT synchrotron 
techniques for imaging bovine and human ovaries ex vivo. Overall, we concluded that TGI-CT 
provided greater contrast resolution for visualizing ovarian anatomy compared to conventional 
2D ultrasonography.  PB-CT was superior to ultrasonography for detecting small antral follicles 
<2mm, cell layers of the follicle wall and COC, and equivalent to ultrasonography for measuring 
follicle and luteal diameters. However, PB-CT was inferior to ultrasonography for visualizing 
non-cystic CL. We obtained preliminary data to demonstrate that TGI-CT provided the greatest 
contrast for visualizing ovarian microanatomy compared to both PB-CT and ultrasonography. 
Thus, our hypotheses were only partially supported. 
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The follicle is considered the structural and functional unit of an ovary. As such, the 
ability to evaluate follicular morphology is crucial for our understanding of normal and abnormal 
female reproductive function. PB-CT imaging was as effective as ultrasonography for measuring 
antral follicles ≥2 mm in bovine and human ovaries. However, the detection of small antral 
follicles <2 mm with PB-CT was superior compared to ultrasonography. The detection of small 
antral follicles has the potential to enhance our knowledge about early follicular development 
[53, 55, 56]. Bovine and human follicle wall thickness measurements were more accurate with 
PB-CT versus ultrasonography when both methods were compared with histology. Furthermore, 
the granulosa and theca layers of the follicle wall could be distinguished on the PB-CT, but not 
ultrasonographic, images. Ultrasonographic biomicroscopy of human ovaries ex vivo has 
previously been found to be effective for detecting antral follicles <2 mm and the layers of the 
follicular wall, but was limited in measuring follicles > 7mm [54]. TGI-CT provided more 
contrast resolution than PB-CT and ultrasonography for delineating antral follicles from the 
surrounding stromal tissues. TGI-CT appears to be more promising for measuring antral follicles 
of all sizes and the follicle wall compared to PB-CT, but quantitative comparisons are required to 
verify these preliminary findings.  
We were able to visualize spherical structures within the follicular antrum using PB-CT. 
We postulated that the spherical structures detected using the synchrotron were COC due to their 
size, location and similarity in attributes to COC visualized in the previous ultrasound 
biomicroscopy study in humans [54] and domestic farm animals [55]. Furthermore, circular 
structures consistent with oocytes within the COC were identified in the TGI-CT images, but not 
the corresponding PB-CT and ultrasonographic images. We were not able to visualize COC in 
the human ovaries because of a low follicle count. Lower follicle counts were primarily 
attributed to the older age of participants in our study. Additional factors which may have 
influenced follicle counts include genetics, environmental contaminants, and smoking [57]. 
Further studies should be conducted with an emphasis on visualizing human COC using PB-CT 
and TGI-CT, preferably with samples from women of reproductive-age (i.e., 18 – 30 years). 
Synchrotron-based Fourier transform-infrared (FT-IR) microspectroscopy has been used to 
effectively evaluate the composition, biochemistry and distribution of biological components 
(i.e., lipid depositions) in mouse oocytes ex vivo [56]. Furthermore, synchrotron-based X-ray 
fluorescence microscopy has been used to evaluate elemental mapping on frog oocytes and 
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embryos ex vivo [58]. The findings from our study provide rationale for evaluating the 
microanatomy and chemical composition of human oocytes using synchrotron techniques. 
Currently, the visualization of the oocyte in women in vivo is not possible. The ability to 
visualize the oocyte in vivo would be a tremendous advancement to understanding oocyte 
development, and female reproductive potential [59]. 
Accurate identification of the CL is imperative for the assessment of ovulation and luteal 
function in women undergoing fertility investigations and/or assisted reproduction [12, 60]. PB-
CT was also as effective as ultrasonography for measuring luteal diameter.  However, the 
contrast resolution for detecting and differentiating follicles from no-cystic CL was inferior with 
PB-CT. Neither PB-CT nor ultrasonography was capable of detecting all CL that were visualized 
histologically. The invaginations of the luteal wall in cystic CL were better visualized with PB-
CT than ultrasonography. TGI-CT provided greater contrast for visualizing CL with and without 
a central cystic cavity compared to PB-CT. Therefore, we concluded that TGI-CT was a more 
promising tool for visualizing the CL compared to PB-CT.  
Follicle and luteal vasculature was also better visualized using TGI-CT versus PB-CT 
and ultrasonography. Thus, the microscopic details visualized in the TGI-CT images of the 
ovaries appeared to better resemble histology than PB-CT. The multiple scans obtained with CT 
synchrotron techniques enabled us to evaluate the ovary in serial cross sections and track the 
appearance of follicles within. Therefore, PB-CT and TGI-CT techniques were more suitable for 
identifying individual follicles than single projection images obtained previously using planar 
DEI (Chapter 3) [35]. Our study findings can also be used to determine and predict suitable 
parameters for synchrotron imaging for other types of soft tissues, such as the prostate and 
breast.  Similarities in the capabilities of synchrotron methods for imaging both bovine and 
human ovaries further supports the idea that the bovine species is an appropriate model for 
studying human ovarian structure and function [10, 61].  
One of the biggest limitation of this study was the time required for imaging the ovaries 
using synchrotron techniques. The total length of time required for sample set-up, beamline 
preparation, and imaging of a whole ovary (dimensions of approximately 3 x 2 x 1.5 cm) was 
about 8 hours. Therefore, imaging time limited the number of ovaries we could evaluate. 
Furthermore, we were not able to confirm the detection of COC in the synchrotron images 
histologically, because we were only able to analyze ¼ of the entire ovary in a reasonable period 
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of time. Imaging a greater number of ovarian specimens and a greater number of slices/specimen 
would have increased the probability of detecting COC in the correspondent histologic images. 
However, these modifications were not practical to implement over the duration of our pilot 
study.  Another limitation of our study was the presence of ring artifacts in the PB-CT images 
which decreased our ability to resolve ovarian microanatomy.  Ring artifacts were attributed to 
imperfect detector elements and were therefore removed using customized software in the 
present study [48, 50].  However, removal of the artifacts resulted in an overall reduction in 
image quality.  We propose that use of a different detector type in future studies may improve the 
quality of synchrotron images.  
Infrastructural differences, technical capabilities between SPring-8 and the CLS, and 
study design must be taken into consideration when visually comparing the PB-CT and TGI-CT 
images. The study was not designed to quantitatively compare PB-CT and TGI-CT techniques; 
only a single bovine and a single human ovary were imaged at Spring-8. It is also important to 
consider that the SPring-8 synchrotron is a larger facility and operates at a higher energy 
compared to the CLS (8.0 GeV vs. 2.9 GeV).  Ovaries were embedded in agarose gel for TGI-
CT imaging, compared to preparation in saline for PB-CT. The powerful energy source available 
at SPring-8 and stabilization of samples may have contributed to the improved contrast in the 
TGI-CT images of the ovaries. We could not rule out the processes implemented at different 
synchrotron facilities as confounding factor in this study. The establishment of a TGI-CT 
imaging system at the CLS and preliminary investigations on the use of TGI-CT to image soft 
tissues including ovarian samples are currently underway.  
Future synchrotron studies should focus on improving PB-CT image quality and 
comparing our TGI-CT findings with ultrasonography and histology. Imaging of ovaries with a 
combination of two or more synchrotron-based phase-contrast techniques, such as DEI and PB-
CT should also be examined in prospective studies [25]. We hope that our study findings will 
lead to the development of novel techniques for imaging reproductive tissues in vivo. The 
clinical applications of imaging human ovaries in vivo using synchrotron techniques are not fully 
understood. To ensure patient safety, a suitable energy and safe radiation exposure time is 
required without compromising the resolution and quality of the images [39, 62]. Developing 
methods to reduce imaging and reconstruction time will make the synchrotron a more suitable 
tool for conducting in vivo research and clinical work. In vivo imaging of ovaries may help 
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determine the underlying causes of reproductive dysfunctions and enhance our understanding of 
ovarian anatomy and physiology [63].   
In summary, we have determined that PB-CT is as effective for visualizing ovarian 
macroanatomy (i.e., antral follicles ≥ 2mm and cystic-CL), and superior for detecting ovarian 
microanatomy (i.e., small antral follicles <2 mm, follicle wall, COC) compared to conventional 
ultrasonography.  Preliminary findings from our SPring-8 study have further indicated that TGI-
CT appears to be even more promising than PB-CT for imaging ovaries. Future research should 
focus on evaluating fresh human ovaries using TGI-CT,    
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Chapter 5 
GENERAL DISCUSSION 
 
The ovary is the primary endocrine organ of the female reproductive system. The ovary 
contains follicles which house the female germ cells or “oocytes”. Hormonal secretions from the 
ovary regulate the growth of both follicles and oocytes, and regulate development of the uterine 
lining throughout the menstrual cycle. The development of non-invasive imaging techniques 
over the past 40 years has provided a greater understanding of female reproductive function and 
dysfunction. The most common modality for imaging the ovaries in vivo is conventional 2D 
ultrasonography. However, the current resolution of ultrasonography prevents the accurate and 
consistent detection of the structures <2 mm in the ovaries [1, 2]. As such, the development of 
novel high-resolution techniques for imaging the ovaries is required.  
X-ray imaging has been used for more than 80 years to assist in clinical diagnoses and to 
guide surgical procedures [3]. The optimization of X-ray techniques has led to the development 
of various biomedical applications, including synchrotron imaging. The synchrotron accelerates 
electrons in a circular path, which results in the generation of high-energy electromagnetic light 
[4]. Medical applications of synchrotron light include, but are not limited to, mammography, 
angiography, microtomography, bronchography and radiotherapy [3]. The use of early 
synchrotron technologies for imaging bovine ovaries ex vivo was conducted in 2002 at the 
University of Saskatchewan. The investigators of this proof-of-principle study visualized 
follicles >4 mm and corpora lutea within the bovine ovary using synchrotron-based Diffraction 
Enhanced Imaging (DEI) [5]. However, comparisons of synchrotron imaging with conventional 
imaging methods were not made. To date, the effectiveness of synchrotron techniques for 
imaging ovaries is not fully understood.  The studies conducted as constituents of this thesis are a 
progression from initial research at the University of Saskatchewan to qualitatively and 
quantitatively compare synchrotron techniques for imaging bovine and human ovaries with 
conventional 2D ultrasonography and histology.  
We conducted two studies at the Canadian Light Source to examine synchrotron imaging 
of ovaries ex vivo. Diffraction Enhanced Imaging (DEI) (Chapter 3) and Propagation-based 
Computed Tomography (PB-CT) (Chapter 4) synchrotron techniques were evaluated to image 
bovine and human ovaries. We conducted a third study, in collaboration with scientists at the 
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SPring-8 Synchrotron Facility in Japan, to explore the usefulness of Talbot Grating 
Interferometry-Computed Tomography (TGI-CT) for imaging bovine and human ovaries 
(Chapter 5). Qualitative and quantitative image attributes obtained with DEI and PB-CT were 
compared with both conventional 2D ultrasonographic images and histologic images. Qualitative 
comparisons were made between images obtained using DEI-CT, PB-CT, and TGI-CT.  
Qualitative endpoints included the detection and differentiation of ovarian structures of interest 
(i.e., follicles, cell layers comprising the follicle wall, corpora lutea and cumulus oocyte 
complexes). Quantitative evaluations included comparisons of follicle and luteal diameter, Antral 
Follicle Count, follicle wall thickness, and the smallest antral follicle detected. The bovine 
species has been previously validated as a model for studying human reproductive function [6-9]. 
Thus, bovine ovaries were included in the first phase of our research, with subsequent phases 
conducted to evaluate preserved and fresh human ovaries. Results from the initial bovine 
investigations were used to develop and optimize the experimental conditions for imaging human 
ovaries with the synchrotron. No differences in synchrotron image quality were detected between 
fresh and preserved ovarian samples; these findings were consistent with previous research to 
evaluate human articular cartilage [10] and human breast tissue [11].    
Overall, we demonstrated that DEI was not an effective technique for visualizing antral 
follicles, corpora lutea, and cumulus oocyte complexes when compared to ultrasonography and 
histology. PB-CT was as effective as ultrasonography for measuring follicle and luteal diameter. 
Furthermore, PB-CT was superior to ultrasonography for detecting small antral follicles <2 mm, 
the cell layers comprising the follicle wall and cumulus oocyte complexes. However, preliminary 
data suggested that TGI-CT provided the greatest contrast resolution for visualizing antral 
follicles, the follicle wall, corpora lutea, cumulus oocyte complexes and vasculature compared to 
both PB-CT and ultrasonography. Therefore, the general hypothesis that synchrotron techniques 
would provide greater contrast resolution for imaging ovaries when compared to ultrasonography 
was partially supported.  
5.1 Diffraction Enhanced Imaging 
DEI enabled the visualization of ovarian follicles ≥2mm and corpora lutea, but not small 
follicles <2mm, cumulus oocyte complexes, the granulosa and theca cell layers comprising the 
follicle wall, or vasculature. Approximately 2/3 of all antral follicles and corpora lutea that were 
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visualized with ultrasonography were visualized with DEI. With that said, Antral Follicle Count 
(defined as the number of follicles ≥2mm) did not statistically differ between DEI and 
ultrasonography. Similarly, diameter measurements of follicles >2mm and corpora lutea did not 
differ among DEI, ultrasonographic, and histologic images. We attributed the lack of statistical 
differences between groups, at least in part, to a small sample size. 
Accurate assessment of the number and diameter of antral follicles and corpora lutea is 
clinically relevant for monitoring ovarian function during natural menstrual cycles, predicting the 
ovarian response to human assisted reproductive treatment, as well as determining the timing of 
the onset of menopause [7, 12, 13].  The differentiation of antral follicles from corpora lutea was 
not possible using DEI, but it was possible using both ultrasonography and histology. We 
attributed the challenge in identifying and differentiating follicles from corpora lutea with DEI to 
the use of projection or planar based imaging rather than CT. We found that the superimposition 
of follicles and luteal glands in the DEI planar images restricted our ability to differentiate 
between the various structures. Furthermore, the small variation in the projected refractive 
indices between the luteal tissues and follicles (presumably due to similar tissue densities) may 
have contributed to the similarities in contrast [14]. Our findings are similar to previous reports 
of suboptimal Diffraction Enhanced image interpretation of human breast tissue caused by 
superimposition of tissue structures [15].   
One advantage that planar DEI demonstrated over PB-CT and TGI-CT was a shorter 
imaging duration, irrespective of the time taken for beam set-up and stabilization. Images were 
obtained within minutes using planar DEI, but required hours when performing a CT scan. 
Furthermore, the reconstruction was simpler and less time consuming for planar DEI compared 
to tomographic reconstruction required for PB-CT. Despite these advantages, planar DEI did not 
prove to be a superior method for imaging the ovaries compared to conventional 2D 
ultrasonography.  By comparison, DEI-CT is a technique which involves obtaining multiple DEI 
projection images of a sample. Thus, DEI-CT can be used to construct 3D volumetric images of 
objects. DEI-CT was not used in the present study.  However, it is plausible that DEI-CT will be 
a more effective modality for visualizing ovarian microanatomy (i.e., follicles, corpora lutea, 
cumulus oocyte complexes, composition of the follicle wall) compared to planar methods. We 
postulate that the incorporation of an additional plane of imaging will improve the resolution of 
follicles and corpora lutea within ovaries [16-18]. 
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5.2 Propagation-Based CT Imaging 
PB-CT was as effective as ultrasonography for measuring the diameter of follicles ≥2mm 
and corpora lutea. However, identifying the corpora lutea (especially corpora lutea that did not 
contain a central cystic cavity) was very challenging in PB-CT images. The image contrast of 
non-cystic corpora lutea and surrounding stromal tissues was very similar, making it difficult to 
identify the corpora lutea within the ovaries. Cystic corpora lutea were more easily visualized 
with PB-CT because of a greater contrast resolution between the fluid within the cavity and the 
neighboring luteal tissues. The difference in follicular and luteal echogenicity in the 
ultrasonographic images was greater (i.e., more obvious) compared to the difference in follicular 
versus luteal contrast in the PB-CT images. Therefore, we concluded that ultrasonography was 
more effective than PB-CT for differentiating corpora lutea and follicles. The imaging of 
follicles and corpora lutea is crucial for evaluating female reproductive function and dysfunction. 
It has been previously shown that the brightness of pixels in ultrasonographic images changes 
during stages the menstrual/estrous cycle, in association with morphologic and endocrinologic 
aspects of follicle and luteal development [19, 20].  Similar studies evaluating synchrotron 
imaging of ovarian follicle and luteal development in vivo have not yet been conducted.  
PB-CT provided an advantage over ultrasonography for detecting small antral follicles <2 
mm (minimum diameter = 0.85 ± 0.42 mm for PB-CT versus 2.18 ± 0.18 mm for 
ultrasonography). Similarly, spherical structures protruding from the follicle wall (resembling 
cumulus oocyte complexes) as well as the cell layers comprising the follicle wall were visualized 
with PB-CT, but not ultrasonography. It has been previously documented that conventional 
ultrasonography is not a reliable tool for visualizing cumulus oocyte complexes during the 
spontaneous menstrual cycle [21] or in-vitro fertilization cycles [22]. Moreover, detection of 
cumulus oocyte complexes using ultrasonography has been limited to only those follicles that are 
>15 mm in diameter.  Researchers in our lab have recently documented the visualization of 
follicles <2 mm and cumulus oocyte complexes in human ovaries [23] and domestic farm 
animals [24] using ultrasound biomicroscopy. However, the depth of tissue penetration with 
ultrasound biomicroscopy is limited, depending on the resolution of the transducer that you use 
[23]. In the present study, we were able to visualize the cumulus oocyte complexes in follicles as 
small as 2 mm in diameter, while imaging the entire ovary. Limitations to the depth of imaging 
observed previously with ultrasound biomicroscopy were not observed with PB-CT imaging. 
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Therefore, we conclude that PB-CT synchrotron imaging provides an advantage over both 
conventional and biomicroscopic ultrasonography for imaging the cumulus oocyte complexes. 
 Doppler ultrasonographic imaging is used to assess ovarian vasculature in relation to the 
normal follicular and corpora lutea function as well as the development of ovarian malignancies 
[25-27]. Doppler ultrasonography was not a focus of this thesis and was not evaluated in our 
investigations.  However, vasculature was visualized using PB-CT (but not DEI), following the 
injection of radiographic contrast into the ovarian artery of 1/3 bovine ovaries.  Vasculature 
surrounding individual dominant follicles was visualized, albeit not consistently. Technical 
difficulties in injecting contrast into the ovarian arteries (i.e., ligation of very small vessels, time-
sensitive nature of the injections post-ovariectomy) may have contributed, in part, to the poor 
visualization of vasculature in our samples. Continued research should be conducted to 
determine the effectiveness of DEI and PB-CT synchrotron techniques for imaging bovine and 
human ovaries.  
 5.3 Talbot Grating Interferometry-CT Imaging 
 TGI-CT imaging of bovine and human ovaries was conducted as a case series due to 
technical, practical and ethical challenges in shipping ovarian tissues to Japan for evaluation at 
the SPring-8 facility. As a result, TGI-CT was conducted on a single preserved bovine ovary and 
a single preserved human ovarian tissue segment. We visually observed a remarkable 
improvement in contrast in the TGI-CT images compared to PB-CT images. Specifically, we 
saw a clear delineation of individual structures within the ovary, such as follicles, non-cystic and 
cystic corpora lutea, granulosa and theca cells layers of the follicle wall, cumulus oocyte 
complexes, and vasculature. Small antral follicles <2mm were detected in TGI-CT, but not PB-
CT or ultrasonographic images. The contrast resolution of the TGI-CT images also show promise 
for visualizing pre-antral follicles (i.e., <0.2 mm) which is not possible with current 
ultrasonographic technology. The entire duration of follicle development from the primordial to 
preovulatory stage is approximately 175 days [28].  Development of antral follicles beyond 2 
mm comprises only about 15 days of the entire lifespan of follicle development [28].  Thus, 
visualization of small antral follicles is necessary to increase our knowledge about early stages of 
follicle growth, which are not well understood. A greater understanding about pre-antral and 
early antral folliculogenesis has clinical applications for monitoring follicle development, 
83 
 
determining early symptoms of ovarian pathophysiology and for improving treatments for 
infertility.  
 Cumulus oocyte complexes were more consistently observed protruding from the follicle 
wall in TGI-CT versus PB-CT images. Furthermore, the oocyte was observed as a bright circular 
structure within the cumulus oocyte complexes in TGI-CT, but not PB-CT, images. In contrast, 
no cumulus oocyte complexes were observed ultrasonographically in our study. Currently, 
oocytes are visualized histologically (following surgical removal of the ovaries) or by 
microscopic evaluation of aspirated oocytes in vitro. More recently, ultrasound biomicroscopy 
has been used to image bovine cumulus-oocyte complexes in vivo; the resolution of the images 
obtained and the depth of penetration for imaging the ovaries was limited [24].  In addition, 
synchrotron-based FT-IR research methods have been used to examine the composition and 
biochemical properties of animal oocytes in-culture [29, 30].  Our findings are novel in that we 
documented the visualization of both cumulus oocyte complexes and oocytes within the cumulus 
cells in both bovine and human ovaries. The resolution of images obtained in the present study 
appeared greater than that obtained in previous studies [24, 29, 30]. Based on these exciting 
findings, we believe that TGI-CT has potential to provide great benefit for evaluating oocyte 
development, documenting ovulation, and increasing our understanding of follicle-oocyte 
interactions in both animals and humans [31].  We believe that TGI-CT methods used in our 
research may also be applied to the future development of novel synchrotron imaging techniques 
for other soft tissues, such as tissues of the breast, brain, heart, kidney and prostate. 
 We believe that improvements in image quality obtained with TGI-CT versus PB-CT 
were primarily attributed to differences in hardware and software (i.e., technical capabilities) 
available at the SPring-8 versus CLS synchrotron facilities. Statistical comparisons of TGI-CT 
versus PB-CT images were not possible due to the small number of samples imaged with TGI-
CT.  However, the establishment of a TGI-CT system is currently underway at the CLS. We 
expect that TGI-CT images obtained at the CLS will be similar to those obtained at SPring-8 in 
Japan. The establishment of TGI-CT at the CLS has the potential to markedly improve 
biomedical imaging of soft tissues, and will be an important step for the development of novel, in 
vivo high-resolution synchrotron imaging of soft tissues. 
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5.4 Future Directions and Clinical Applications 
The results presented in the thesis have provided important information about imaging of 
ovaries using synchrotron techniques. We have come a long way in our ability to image ovarian 
structure and function. However, continued research is required to build upon the present 
findings to further evaluate synchrotron techniques for imaging ovaries. We believe that 
strategies to improve synchrotron ovarian imaging in the future should include optimizing X-ray 
energy, increasing signal filtrations to reduce noise, and enhancing detector sensitivity to 
minimize ring artifacts. Findings from the studies presented indicate that TGI-CT is a more 
promising technology than DEI and PB-CT for imaging ovaries. Therefore, we propose that 
future studies should focus on quantitatively comparing TGI-CT of fresh human ovaries with 
ultrasonography and histology to confirm whether TGI-CT is superior to conventional imaging 
techniques. In addition, the effectiveness of  DEI-CT for imaging human ovaries is not currently 
known and requires further investigation [32].  
The biomedical imaging applications of synchrotron techniques have been initially 
investigated in animal and human tissue samples or whole animals post-mortem. Limited studies 
have been conducted in live animals and no research has been conducted yet in men and women 
in vivo. Synchrotron-based PB-CT techniques have been used previously to examine lung 
function in live mice [33] and rabbits [34]. PB-CT imaging in live mice was found to be effective 
for visualizing fine micron sized structures, as well as natural movements of internal organs [35]. 
A clinical system for imaging human breast tissues using synchrotron phase contrast techniques 
has already been implemented at the ELETTRA synchrotron in Italy [36, 37]. Further research is 
required to establish a synchrotron-based system for in vivo imaging of human and animal 
reproductive organs, including ovaries. Synchrotron imaging of ovaries has the potential to be 
used for detecting reproductive dysfunction, including benign and malignant ovarian cysts and 
masses. Clinical in vivo imaging of ovaries with the synchrotron will require a suitable energy 
and safe radiation exposure time without compromising the image contrast [38-40]. 
Tomographic imaging of live humans and animals may be challenging because, unlike 
conventional CT imaging, the sample is rotated and the X-ray beam is stationary. With that said, 
the speed at which the samples are rotated is slow (i.e., 20 seconds for one degree turn) and 
should not lead to patient discomfort. Living animals or humans can also produce motion 
artifacts due to subtle movements such as respiration [41]. Continued research to optimize 
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imaging parameters, decrease imaging time, and maximize patient safety and comfort can help to 
overcome the present challenges in synchrotron imaging of ovaries. Synchrotron techniques have 
the potential to image soft tissues at greater resolution and lower radiation exposure compared to 
X-ray CT and Magnetic Resonance Imaging. The ultimate goal of continued research in this area 
is to incorporate synchrotron techniques into clinical practice that will likely improve patient 
care and well-being.   
5.5 Significance  
As part of the research work presented in this thesis, we were able explore the advantages 
and limitations of synchrotron based-imaging techniques for visualizing human and bovine 
ovaries. We were able to determine that synchrotron techniques, especially TGI-CT, are capable 
of detecting structures that are undetected by conventional ultrasonographic imaging methods 
(i.e., oocyte, cumulus oocyte complexes, cell layers of the follicle wall and follicles <2mm).  
Therefore, the synchrotron holds great potential for investigating early antral and pre-antral 
folliculogenesis, oogenesis and luteogenesis. The improved contrast resolution of synchrotron 
images also show promise for differentiating between normal ovaries and those containing 
pathology (i.e., ovarian tumors and malignant cysts). As such, the synchrotron can be used as a 
tool for understanding early determinants of fertility. Our research methodology and findings 
may be applied to synchrotron imaging of other types of soft tissues, such as breast, prostate and 
kidney. Furthermore, our work can be used as a guide for optimizing beamline instrumentation 
and image reconstruction programs for improving synchrotron biomedical imaging in Canada 
and abroad. 
5.6 Summary 
In summary, DEI was not found to be an effective technique for evaluating ovarian 
anatomy compared to ultrasonography. In contrast, PB-CT was equally effective to 
ultrasonography for detecting and measuring follicles ≥2mm and corpora lutea. The resolution 
for visualizing structural details within follicles and corpora lutea was superior for PB-CT versus 
ultrasonography; however, PB-CT did not allow the differentiation of follicles from non-cystic 
corpora lutea within the ovaries. Finally, we obtained preliminary data to indicate that TGI-CT 
synchrotron imaging provides the greatest contrast resolution for visualizing ovarian macro- and 
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micro-anatomy, including follicles, corpora lutea, the cell layers comprising the follicle wall and 
oocytes, compared to both PB-CT and conventional 2D ultrasonography. We believe that future 
research to develop synchrotron methods for imaging soft tissues in animals and humans should 
be focused on TGI-CT imaging.  
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Chapter 6 
GENERAL CONCLUSIONS 
 
The studies conducted in this thesis provided detailed information regarding synchrotron 
biomedical techniques for imaging bovine and human ovaries, in comparison to ultrasonography 
and histology. The specific conclusions derived from the study findings are listed below. 
1. DEI did not provide an advantage over ultrasonography for detecting ovarian anatomy. 
a. DEI was as effective as ultrasonography for measuring antral follicles ≥2 mm and 
corpora lutea; however, the resolution for differentiating follicular and luteal 
anatomy was inferior with DEI.  
b. Neither DEI nor ultrasonography allowed the visualization of antral follicles <2 
mm, follicle wall and cumulus oocyte complexes.  
 
2. PB-CT imaging provided an advantage over ultrasonography for visualizing ovarian 
anatomy. 
a. PB-CT was as effective as ultrasonography for detecting and measuring follicles 
≥2 mm and cystic corpora lutea. However, the ability to differentiate antral 
follicles from non-cystic corpora lutea was inferior with PB-CT versus 
ultrasonography.  
b. PB-CT was superior to ultrasonography for visualizing small antral follicles <2 
mm, the theca and granulosa cell layers comprising the follicle wall, and cumulus 
oocyte complexes. 
 
3. TGI-CT appeared to provide an advantage over ultrasonography for visualizing both 
macro- and microanatomy of the ovary. 
a. TGI-CT provided superior contrast resolution for visualizing antral follicles, theca 
and granulosa cell layers comprising the follicle wall, cystic and non-cystic 
corpora lutea, cumulus oocyte complexes, oocytes, and vasculature, compared to 
both PB-CT and ultrasonography. 
